JAK3
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A0AVT1 | Y1046 | Sugiyama | UBA6 MOP4 UBE1L2 | VSFAPDIDGDEDLPGPPVRYyFsHDTD______________ |
| A0FGR8 | Y824 | Sugiyama | ESYT2 FAM62B KIAA1228 | IVVVHACRNLIAFSEDGsDPyVRMYLLPDKRRSGRRKTHVS |
| A0MZ66 | Y24 | Sugiyama | SHTN1 KIAA1598 | sDEEKQLQLITsLKEQAIGEyEDLRAENQKTKEKCDKIRQE |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A5YKK6 | Y851 | Sugiyama | CNOT1 CDC39 KIAA1007 NOT1 AD-005 | QVWPEANQHFSKEIDDEANSyFQRIYNHPPHPTMSVDEVLE |
| A6NEC2 | Y295 | Sugiyama | NPEPPSL1 | AEQGKFALEVAAKTLPFYKDyFNVPYPLPKIDLIAIADFAA |
| A6NMY6 | Y333 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| O00115 | Y53 | Sugiyama | DNASE2 DNASE2A DNL2 | YKLPALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEG |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00193 | Y84 | Sugiyama | SMAP C11orf58 | TSHFRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGF |
| O00233 | Y70 | Sugiyama | PSMD9 | IGMNEPLVDCEGyPRSDVDLyQVRTARHNIICLQNDHKAVM |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00429 | Y266 | Sugiyama | DNM1L DLP1 DRP1 | NRSQLDINNKKSVTDsIRDEyAFLQKKYPSLANRNGTKYLA |
| O00469 | Y199 | Sugiyama | PLOD2 | IVQQWNLQDNDDDQLFyTKVyIDPLKREAINITLDHKCKIF |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00469 | Y586 | Sugiyama | PLOD2 | FWFPIFSEKACDELVEEMEHyGKWSGGKHHDsRIsGGyENV |
| O00469 | Y603 | Sugiyama | PLOD2 | MEHyGKWSGGKHHDsRIsGGyENVPTDDIHMKQVDLENVWL |
| O00507 | Y1817 | Sugiyama | USP9Y DFFRY | IQLKRFDYDWERECAIKFNDyFEFPRELDMGPYTVAGVANL |
| O00625 | Y131 | Sugiyama | PIR | AHGLQLWVNLRSSEKMVEPQyQELKSEEIPKPSKDGVTVAV |
| O14579 | Y27 | Sugiyama | COPE | GPAsGGsGEVDELFDVKNAFyIGSyQQCINEAQRVKLSsPE |
| O14579 | Y304 | Sugiyama | COPE | HPFIKEYQAKENDFDRLVLQyAPsA________________ |
| O14579 | Y31 | Sugiyama | COPE | GGsGEVDELFDVKNAFyIGSyQQCINEAQRVKLSsPERDVE |
| O14579 | Y90 | Sugiyama | COPE | LDEIKPsSAPELQAVRMFADyLAHEsRRDsIVAELDREMsR |
| O14639 | Y439 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | ERQsLGEsPRtLsPtPsAEGyQDVRDRMIHRstsQGsINsP |
| O14672 | Y415 | Sugiyama | ADAM10 KUZ MADM | SGTECTPGESKNLGQKENGNyIMYARATSGDKLNNNKFSLC |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O14939 | Y415 | SIGNOR|EPSD|PSP | PLD2 | VRVSILLFKEVELALGINSGySKRALMLLHPNIKVMRHPDQ |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14964 | Y216 | Sugiyama | HGS HRS | KYSTIPKFGIEKEVRVCEPCyEQLNRKAEGKAtsttELPPE |
| O14974 | Y901 | Sugiyama | PPP1R12A MBS MYPT1 | EtQtDsIsRyETssTsAGDRyDsLLGRsGsysYLEERKPYS |
| O14974 | Y911 | Sugiyama | PPP1R12A MBS MYPT1 | ETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTD |
| O14980 | Y469 | Sugiyama | XPO1 CRM1 | DsINLyKNMRETLVyLTHLDyVDTERIMTEKLHNQVNGTEW |
| O15013 | Y1307 | Sugiyama | ARHGEF10 KIAA0294 | sLsLsHGsssLEHRSEDsTIyDLLKDPVSLRSKARRAKKAK |
| O15212 | Y82 | Sugiyama | PFDN6 HKE2 PFD6 | PVLVKQELGEARAtVGKRLDyItAEIKRYESQLRDLERQsE |
| O15226 | Y657 | Sugiyama | NKRF ITBA4 NRF | HQIAQKYGLKSKSHGVGHDRyLVVGRKRRKEDLLDQLKQEG |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15305 | Y205 | Sugiyama | PMM2 | DGWDKRYCLRHVENDGYKTIyFFGDKTMPGGNDHEIFTDPR |
| O15371 | Y202 | Sugiyama | EIF3D EIF3S7 | MRyLEVSEPQDIECCGALEyyDKAFDRITTRSEKPLRSIKR |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O15372 | Y350 | Sugiyama | EIF3H EIF3S3 | IKEFTAQNLGKLFMAQALQEyNN__________________ |
| O15460 | Y79 | Sugiyama | P4HA2 UNQ290/PRO330 | KSWANKMEALTSKSAADAEGyLAHPVNAyKLVKRLNTDWPA |
| O15460 | Y87 | Sugiyama | P4HA2 UNQ290/PRO330 | ALTSKSAADAEGyLAHPVNAyKLVKRLNTDWPALEDLVLQD |
| O43237 | Y184 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | KIPPEKMRELERKFVKDFQDyMEPEEGCQGsPQRRGPLtsG |
| O43252 | Y617 | Sugiyama | PAPSS1 ATPSK1 PAPSS | EGQKPPEGFMAPKAWtVLtEyyKSLEKA_____________ |
| O43252 | Y618 | Sugiyama | PAPSS1 ATPSK1 PAPSS | GQKPPEGFMAPKAWtVLtEyyKSLEKA______________ |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43399 | Y106 | Sugiyama | TPD52L2 | LGELKQNLsRsWHDVQVssAyVKTSEKLGEWNEKVTQSDLy |
| O43432 | Y952 | Sugiyama | EIF4G3 | LLTTIGKDLDFEKAKPRMDQyFNQMEKIVKERKTSSRIRFM |
| O43615 | Y201 | Sugiyama | TIMM44 MIMT44 TIM44 | QGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKFKEE |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y397 | Sugiyama | ACTN4 | GKMVSDINNGWQHLEQAEKGyEEWLLNEIRRLERLDHLAEK |
| O43707 | Y441 | Sugiyama | ACTN4 | KAsIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEs |
| O43707 | Y533 | Sugiyama | ACTN4 | REALEKTEKQLEAIDQLHLEyAKRAAPFNNWMESAMEDLQD |
| O43707 | Y611 | Sugiyama | ACTN4 | HKEAQRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVP |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43707 | Y898 | Sugiyama | ACTN4 | yCIARMAPyQGPDAVPGALDyKsFStALyGEsDL_______ |
| O43765 | Y158 | Sugiyama | SGTA SGT SGT1 | LGNyAGAVQDCERAICIDPAySKAYGRMGLALSSLNKHVEA |
| O43776 | Y45 | Sugiyama | NARS1 NARS NRS | PFKTGLKALMTVGKEPFPtIyVDsQKENERWNVISKsQLKN |
| O43795 | Y234 | Sugiyama | MYO1B | GASEELLNKLKLERDFSRyNyLSLDSAKVNGVDDAANFRTV |
| O43813 | Y21 | Sugiyama | LANCL1 GPR69A | MAQRAFPNPyADyNKsLAEGyFDAAGRLTPEFSQRLTNKIR |
| O43852 | T224 | Sugiyama | CALU | ADGFIDLEEyIGDMysHDGNtDEPEWVKTEREQFVEFRDKN |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y129 | Sugiyama | CALU | VERQWKGHDLNEDGLVsWEEyKNATYGYVLDDPDPDDGFNY |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y213 | Sugiyama | CALU | VQEtMEDIDKNADGFIDLEEyIGDMysHDGNtDEPEWVKTE |
| O43852 | Y218 | Sugiyama | CALU | EDIDKNADGFIDLEEyIGDMysHDGNtDEPEWVKTEREQFV |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y28 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | PLPGVGEELKQAKEIEDAEKysFMATVTKAPKKQIQFADDM |
| O60245 | Y180 | Sugiyama | PCDH7 BHPCDH | TLYLLPTATDRDFGRNGIERyELLQEPGGGGSGGESRRAGA |
| O60264 | Y141 | Sugiyama | SMARCA5 SNF2H WCRF135 | KPGRPRIKKDEKQNLLsVGDyRHRRTEQEEDEELLTEsSKA |
| O60307 | S885 | Sugiyama | MAST3 KIAA0561 | RLGGPRDPAPEKSRASSSGGsGGGSGGRVPKSAsVsALSLI |
| O60341 | Y120 | Sugiyama | KDM1A AOF2 KDM1 KIAA0601 LSD1 | GIAEtPEGRRTsRRKRAKVEyREMDEsLANLsEDEyysEEE |
| O60341 | Y135 | Sugiyama | KDM1A AOF2 KDM1 KIAA0601 LSD1 | RAKVEyREMDEsLANLsEDEyysEEERNAKAEKEKKLPPPP |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60488 | Y582 | Sugiyama | ACSL4 ACS4 FACL4 LACS4 | DGCLQIIDRKKDLVKLQAGEyVsLGKVEAALKNCPLIDNIC |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60506 | Y47 | Sugiyama | SYNCRIP HNRPQ NSAP1 | FQTLLDAGLPQKVAEKLDEIyVAGLVAHsDLDERAIEALKE |
| O60506 | Y614 | Sugiyama | SYNCRIP HNRPQ NSAP1 | PLQGGDHSGNYGYKSENQEFyQDTFGQQWK___________ |
| O60664 | Y235 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AtsLDGFDVAsVQQQRQEQSyFVRLGsLSERLRQHAyEHsL |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | Y296 | Sugiyama | CTNND1 KIAA0384 | HPEPyGLEDDQRsMGyDDLDyGMMsDyGtARRtGtPsDPRR |
| O60716 | Y302 | Sugiyama | CTNND1 KIAA0384 | LEDDQRsMGyDDLDyGMMsDyGtARRtGtPsDPRRRLRsyE |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60739 | Y54 | Sugiyama | EIF1B | RIQQRNGRKtLttVQGIADDyDKKKLVKAFKKKFACNGtVI |
| O60828 | Y209 | Sugiyama | PQBP1 NPW38 JM26 | KSKKAVSRKDEELDPMDPSsysDAPRGTWstGLPKRNEAKT |
| O60869 | Y109 | Sugiyama | EDF1 | GLtQKDLATKINEKPQVIADyESGRAIPNNQVLGKIERAIG |
| O75083 | Y98 | Sugiyama | WDR1 | VSGKLRIWDTTQKEHLLKyEyQPFAGKIKDIAWTEDSKRIA |
| O75116 | Y871 | Sugiyama | ROCK2 KIAA0619 | ERQDADGQMKELQDQLEAEQyFsTLyKtQVRELKEECEEKT |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75179 | Y1297 | Sugiyama | ANKRD17 GTAR KIAA0697 | NVEHRAKTGLTPLMEAASGGyAEVGRVLLDKGADVNAPPVP |
| O75223 | Y156 | Sugiyama | GGCT C7orf24 CRF21 | sPQYKKIICMGAKENGLPLEyQEKLKAIEPNDytGKVsEEI |
| O75223 | Y168 | Sugiyama | GGCT C7orf24 CRF21 | KENGLPLEyQEKLKAIEPNDytGKVsEEIEDIIKKGETQTL |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75347 | Y94 | Sugiyama | TBCA | AyLDLQRILENEKDLEEAEEyKEARLVLDsVKLEA______ |
| O75348 | T86 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | RGsCstEVEKETQEKMTILQtyFRQNRDEVLDNLLAFVCDI |
| O75348 | Y87 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | GsCstEVEKETQEKMTILQtyFRQNRDEVLDNLLAFVCDIR |
| O75369 | T1579 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | QEGKPKRAIVHDNKDGtyAVtyIPDKtGRYMIGVTYGGDDI |
| O75369 | Y2276 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | EPGNYEVSIKFNDEHIPEsPyLVPVIAPSDDARRLTVMSLQ |
| O75369 | Y2502 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | ANEtssILVEsVTRsstETCysAIPKASSDASKVTSKGAGL |
| O75369 | Y902 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | VQFNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLV |
| O75369 | Y904 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | FNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTY |
| O75391 | Y163 | Sugiyama | SPAG7 | QRQEEEAAQQGPVVVsPAsDyKDKYSHLIGKGAAKDAAHML |
| O75475 | Y18 | Sugiyama | PSIP1 DFS70 LEDGF PSIP2 | ___MTRDFKPGDLIFAKMKGyPHWPARVDEVPDGAVKPPTN |
| O75489 | Y207 | Sugiyama | NDUFS3 | ILTDYGFEGHPFRKDFPLSGyVELRYDDEVKRVVAEPVELA |
| O75533 | Y152 | Sugiyama | SF3B1 SAP155 | RLDPFADGGKtPDPKMNARTyMDVMREQHLTKEEREIRQQL |
| O75533 | Y412 | Sugiyama | SF3B1 SAP155 | IDERNRPLsDEELDAMFPEGyKVLPPPAGYVPIRtPARKLt |
| O75534 | Y597 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | EKVNKtHsVNGItEEADPTIysGKVIRPLRSVDPTQTEYQG |
| O75718 | Y197 | Sugiyama | CRTAP CASP | DDEMMKRNMAYYKSLPGAEDyIKDLETKSyESLFIRAVRAY |
| O75817 | Y20 | Sugiyama | POP7 RPP20 | _MAENREPRGAVEAELDPVEytLRKRLPSRLPRRPNDIyVN |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O94776 | Y11 | Sugiyama | MTA2 MTA1L1 PID | __________MAANMYRVGDyVyFENSSSNPyLVRRIEELN |
| O94776 | Y13 | Sugiyama | MTA2 MTA1L1 PID | ________MAANMYRVGDyVyFENSSSNPyLVRRIEELNKT |
| O94842 | Y591 | Sugiyama | TOX4 C14orf92 KIAA0737 | RCVRsGCENPPIVSKDWDNEyCSNECVVKHCRDVFLAWVAS |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O94919 | Y134 | Sugiyama | ENDOD1 KIAA0830 | EAEAITSVNSLGSKQALNtDyLDsDyQRGQLYPFSLSSDVQ |
| O94925 | Y304 | Sugiyama | GLS GLS1 KIAA0838 | LQSCVKPLKyAIAVNDLGTEyVHRYVGKEPsGLRFNKLFLN |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95340 | Y182 | Sugiyama | PAPSS2 ATPSK2 | GLYKRARAGEIKGFTGIDsDyEKPEtPERVLKTNLSTVSDC |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95359 | Y2519 | Sugiyama | TACC2 | SDLSTFVNETKFssPtEELDyRNsYEIEyMEKIGssLPQDD |
| O95359 | Y2527 | Sugiyama | TACC2 | ETKFssPtEELDyRNsYEIEyMEKIGssLPQDDDAPKKQAL |
| O95376 | Y289 | Sugiyama | ARIH2 ARI2 TRIAD1 HT005 | DCATIRKWLTKCADDSETANyISAHTKDCPKCNICIEKNGG |
| O95425 | Y132 | Sugiyama | SVIL | RRRQLAEKyGLTLDPEADsEyLsRYTKSRKEPDAVEKRGGK |
| O95425 | Y185 | Sugiyama | SVIL | SLYPGTETMGLRTCAGESKDyALHVGDGssDPEVLLNIENQ |
| O95573 | Y591 | Sugiyama | ACSL3 ACS3 FACL3 LACS3 | DGCLKIIDRKKDLVKLQAGEyVsLGKVEAALKNLPLVDNIC |
| O95644 | Y371 | SIGNOR|EPSD|PSP | NFATC1 NFAT2 NFATC | EPVGEDLGsPPPPADFAPEDySSFQHIRKGGFCDQYLAVPQ |
| O95757 | Y30 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | FLNCYIAVARsGGIETIANEySDRCtPACIsLGSRTRAIGN |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| O95757 | Y627 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MIMQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPED |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O95881 | S143 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | KVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQERLtGDAF |
| O95881 | Y139 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | DPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQERLt |
| O95881 | Y141 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | SGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQERLtGD |
| O95926 | Y210 | Sugiyama | SYF2 CBPIN GCIPIP | IEKRDKYSRRRPYNDDADIDyINERNAKFNKKAERFYGKYT |
| O96019 | Y68 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DDGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPL |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y10 | Sugiyama | LDHA PIG19 | ___________MAtLKDQLIyNLLKEEQtPQNKITVVGVGA |
| P00338 | Y172 | Sugiyama | LDHA PIG19 | GFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHGWVLGE |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00491 | Y166 | Sugiyama | PNP NP | PLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGEQRE |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P02786 | Y152 | Sugiyama | TFRC | sEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVENQ |
| P02786 | Y168 | Sugiyama | TFRC | NENsyVPREAGsQKDENLALyVENQFREFKLSKVWRDQHFV |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04040 | Y447 | Sugiyama | CAT | GEVRRFNtANDDNVtQVRAFyVNVLNEEQRKRLCENIAGHL |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04083 | Y21 | Sugiyama | ANXA1 ANX1 LPC1 | MAMVsEFLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPt |
| P04181 | Y55 | Sugiyama | OAT | QGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyLWDVEG |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04406 | Y94 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | ItIFQERDPsKIKWGDAGAEyVVEstGVFttMEKAGAHLQG |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04899 | Y168 | Sugiyama | GNAI2 GNAI2B | QLNDSAAYYLNDLERIAQSDyIPTQQDVLRTRVKTTGIVET |
| P05023 | Y542 | Sugiyama | ATP1A1 | LLHGKEQPLDEELKDAFQNAyLELGGLGERVLGFCHLFLPD |
| P05067 | Y308 | Sugiyama | APP A4 AD1 | REVCSEQAETGPCRAMISRWyFDVTEGKCAPFFyGGCGGNR |
| P05187 | Y441 | Sugiyama | ALPP PLAP | YVLKDGARPDVtEsEsGsPEyRQQSAVPLDEETHAGEDVAV |
| P05362 | Y455 | Sugiyama | ICAM1 | GtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNVL |
| P05387 | Y7 | Sugiyama | RPLP2 D11S2243E RPP2 | ______________MRyVAsyLLAALGGNssPsAKDIKKIL |
| P05455 | Y104 | Sugiyama | SSB | EDKTKIRRsPsKPLPEVTDEyKNDVKNRsVYIKGFPtDAtL |
| P05455 | Y23 | Sugiyama | SSB | ENGDNEKMAALEAKICHQIEyyFGDFNLPRDKFLKEQIKLD |
| P05455 | Y24 | Sugiyama | SSB | NGDNEKMAALEAKICHQIEyyFGDFNLPRDKFLKEQIKLDE |
| P05787 | Y282 | Sugiyama | KRT8 CYK8 | EVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRR |
| P05787 | Y286 | Sugiyama | KRT8 CYK8 | QyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTE |
| P05997 | Y1311 | Sugiyama | COL5A2 | HPARTCDDLKLCHSAKQsGEyWIDPNQGSVEDAIKVYCNME |
| P06132 | Y30 | Sugiyama | UROD | GFPELKNDTFLRAAWGEEtDyTPVWCMRQAGRYLPEFRETR |
| P06730 | Y34 | Sugiyama | EIF4E EIF4EL1 EIF4F | PPttEEEKtEsNQEVANPEHyIKHPLQNRWALWFFKNDKsK |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | Y131 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ILGVsLAVCKAGAVEKGVPLyRHIADLAGNsEVILPVPAFN |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06737 | Y821 | Sugiyama | PYGL | MVLKNIAASGKFSSDRTIKEyAQNIWNVEPsDLKIsLSNES |
| P07195 | Y84 | Sugiyama | LDHB | MDLQHGsLFLQtPKIVADKDysVtANSKIVVVtAGVRQQEG |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y116 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | VRGyPtIKFFRNGDTASPKEytAGREADDIVNWLKKRTGPA |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07355 | Y333 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| P07384 | Y42 | Sugiyama | CAPN1 CANPL1 PIG30 | RARELGLGRHENAIKyLGQDyEQLRVRCLQSGTLFRDEAFP |
| P07437 | Y106 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAES |
| P07437 | Y36 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IGAKFWEVISDEHGIDPTGtyHGDsDLQLDRIsVyyNEAtG |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07686 | Y526 | Sugiyama | HEXB HCC7 | ASAVGERLWSSKDVRDMDDAyDRLTRHRCRMVERGIAAQPL |
| P07686 | Y550 | Sugiyama | HEXB HCC7 | TRHRCRMVERGIAAQPLyAGyCNHENM______________ |
| P07711 | Y311 | Sugiyama | CTSL CTSL1 | DNNKYWLVKNsWGEEWGMGGyVKMAKDRRNHCGIAsAAsyP |
| P07711 | Y330 | Sugiyama | CTSL CTSL1 | GyVKMAKDRRNHCGIAsAAsyPtV_________________ |
| P07737 | Y129 | Sugiyama | PFN1 | tLVLLMGKEGVHGGLINKKCyEMAsHLRRsQY_________ |
| P07814 | T294 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | ETIMKYAEKLIQEGKAyVDDtPAEQMKAEREQRIDSKHRKN |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07814 | Y872 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EAVECLLSLKAQYKEKTGKEyIPGQPPLsQssDssPtRNsE |
| P07858 | Y215 | Sugiyama | CTSB CPSB | RPPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNS |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y465 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IKLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMK |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07900 | Y627 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIEtLR |
| P07942 | Y902 | Sugiyama | LAMB1 | ECLNCQDYTMGHNCERCLAGyYGDPIIGSGDHCRPCPCPDG |
| P08174 | Y224 | Sugiyama | CD55 CR DAF | CLISGSSVQWSDPLPECREIyCPAPPQIDNGIIQGERDHyG |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08621 | Y38 | Sugiyama | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | PIPYLPPLEKLPHEKHHNQPyCGIAPYIREFEDPRDAPPPT |
| P08754 | Y167 | Sugiyama | GNAI3 | QLNDSAsyyLNDLDRISQSNyIPTQQDVLRTRVKTTGIVET |
| P08865 | S138 | Sugiyama | RPSA LAMBR LAMR1 | EPRLLVVTDPRADHQPLtEAsyVNLPtIALCNTDSPLRyVD |
| P08865 | Y156 | Sugiyama | RPSA LAMBR LAMR1 | EAsyVNLPtIALCNTDSPLRyVDIAIPCNNKGAHSVGLMWW |
| P08865 | Y202 | Sugiyama | RPSA LAMBR LAMR1 | VLRMRGTISREHPWEVMPDLyFyRDPEEIEKEEQAAAEKAV |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09234 | Y12 | Sugiyama | SNRPC | _________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKE |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09382 | Y120 | Sugiyama | LGALS1 | KLPDGyEFKFPNRLNLEAINyMAADGDFKIKCVAFD_____ |
| P09496 | Y147 | Sugiyama | CLTA | NSRKQEAEWKEKAIKELEEWyARQDEQLQKTKANNRVADEA |
| P09622 | Y97 | Sugiyama | DLD GCSL LAD PHE3 | GGTCLNVGCIPSKALLNNSHyyHMAHGKDFASRGIEMSEVR |
| P09622 | Y98 | Sugiyama | DLD GCSL LAD PHE3 | GTCLNVGCIPSKALLNNSHyyHMAHGKDFASRGIEMSEVRL |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09651 | Y253 | Sugiyama | HNRNPA1 HNRPA1 | GGGGYGGSGDGyNGFGNDGGyGGGGPGYSGGSRGYGSGGQG |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09960 | Y233 | Sugiyama | LTA4H LTA4 | RQIGPRTLVWSEKEQVEKSAyEFsETEsMLKIAEDLGGPYV |
| P09972 | Y358 | Sugiyama | ALDOC ALDC | AAQGKYEGSGEDGGAAAQsLyIANHAY______________ |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0DPH7 | Y103 | Sugiyama | TUBA3C TUBA2 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIVDLVLDRIR |
| P0DPH7 | Y224 | Sugiyama | TUBA3C TUBA2 | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| P10155 | S19 | Sugiyama | RO60 SSA2 TROVE2 | __MEESVNQMQPLNEKQIANsQDGyVWQVTDMNRLHRFLCF |
| P10398 | Y155 | Sugiyama | ARAF ARAF1 PKS PKS2 | HCSSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRP |
| P10696 | Y438 | Sugiyama | ALPG ALPPL ALPPL2 | YVLKDGARPDVtEsEsGsPEyRQQSAVPLDGETHAGEDVAV |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | Y352 | Sugiyama | LAMC1 LAMB2 | tAEsASECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQD |
| P11047 | Y358 | Sugiyama | LAMC1 LAMB2 | ECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQDNTDGAH |
| P11142 | S153 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | AyLGKtVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNVLRII |
| P11142 | S362 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | RIPKIQKLLQDFFNGKELNKsINPDEAVAyGAAVQAAILsG |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | Y149 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIAEAyLGKtVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNV |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11233 | Y153 | Sugiyama | RALA RAL | DKRQVsVEEAKNRAEQWNVNyVETSAKTRANVDKVFFDLMR |
| P11234 | Y154 | Sugiyama | RALB | ERRQVPVEEARSKAEEWGVQyVETSAKTRANVDKVFFDLMR |
| P11310 | Y67 | Sugiyama | ACADM | EFQATARKFAREEIIPVAAEyDKTGEyPVPLIRRAWELGLM |
| P11413 | Y118 | Sugiyama | G6PD | LEDFFARNsyVAGQyDDAAsyQRLNsHMNALHLGsQANRLF |
| P11413 | Y322 | Sugiyama | G6PD | NVVLGQYVGNPDGEGEATKGyLDDPTVPRGSTTATFAAVVL |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y382 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | PLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINPYQP |
| P12268 | Y509 | Sugiyama | IMPDH2 IMPD2 | KFEKRtssAQVEGGVHsLHsyEKRLF_______________ |
| P12270 | Y140 | Sugiyama | TPR | LEAEKRDLIRTNERLsQELEyLTEDVKRLNEKLKESNTTKG |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y378 | Sugiyama | ACTN1 | GRMVSDINNAWGCLEQVEKGyEEWLLNEIRRLERLDHLAEK |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P12956 | Y30 | Sugiyama | XRCC6 G22P1 | tEGDEEAEEEQEENLEAsGDyKYsGRDsLIFLVDASKAMFE |
| P13073 | Y38 | Sugiyama | COX4I1 COX4 | SVCVRAHESVVKsEDFsLPAyMDRRDHPLPEVAHVKHLSAS |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y101 | Sugiyama | PDIA4 ERP70 ERP72 | TVLLEFYAPWCGHCKQFAPEyEKIANILKDKDPPIPVAKID |
| P13667 | Y278 | Sugiyama | PDIA4 ERP70 ERP72 | FRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTLKQVQE |
| P13667 | Y392 | Sugiyama | PDIA4 ERP70 ERP72 | HMMDVQGstQDsAIKDFVLKyALPLVGHRKVSNDAKRYTRR |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13667 | Y604 | Sugiyama | PDIA4 ERP70 ERP72 | DATANDVPSDRyKVEGFPTIyFAPSGDKKNPVKFEGGDRDL |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13796 | Y462 | Sugiyama | LCP1 PLS2 | VNKPPYPKLGGNMKKLENCNyAVELGKNQAKFsLVGIGGQD |
| P13797 | Y465 | Sugiyama | PLS3 | VNKPPYPKLGANMKKLENCNyAVELGKHPAKFSLVGIGGQD |
| P13798 | Y17 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | ____MERQVLLsEPEEAAALyRGLSRQPALsAACLGPEVtT |
| P13929 | Y131 | Sugiyama | ENO3 | ILGVSLAVCKAGAAEKGVPLyRHIADLAGNPDLILPVPAFN |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P13987 | T85 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | WKFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGT |
| P13987 | Y86 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | KFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTS |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14314 | Y465 | Sugiyama | PRKCSH G19P1 | sLGtWGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLC |
| P14324 | Y349 | Sugiyama | FDPS FPS KIAA1293 | QDNKCSWLVVQCLQRATPEQyQILKENYGQKEAEKVARVKA |
| P14618 | Y105 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AEtIKNVRtAtEsFAsDPILyRPVAVALDTKGPEIRtGLIK |
| P14618 | Y370 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NAVLDGADCIMLSGEtAKGDyPLEAVRMQHLIAREAEAAIy |
| P14618 | Y83 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | EMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPI |
| P14625 | T675 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | sGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIR |
| P14625 | Y258 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GNTLGRGTTITLVLKEEAsDyLELDTIKNLVKKYSQFINFP |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14625 | Y677 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIRDM |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y57 | Sugiyama | COX6B1 COX6B | FHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTDWDEQR |
| P14866 | Y430 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | EKVKFMKSKPGAAMVEMADGyAVDRAITHLNNNFMFGQKLN |
| P14866 | Y474 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | SKQPAIMPGQSyGLEDGsCsyKDFSESRNNRFstPEQAAKN |
| P14868 | Y24 | Sugiyama | DARS1 DARS PIG40 | ASASRKsQEKPREIMDAAEDyAKERyGIssMIQsQEKPDRV |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15328 | Y80 | Sugiyama | FOLR1 FOLR | WRKNACCSTNTSQEAHKDVsyLyRFNWNHCGEMAPACKRHF |
| P15924 | Y56 | Sugiyama | DSP | GtsRMYYSRRGVITDQNsDGyCQtGtMsRHQNQNTIQELLQ |
| P15941 | T1214 | Sugiyama | MUC1 PUM | LDIFPARDTyHPMsEyPtyHtHGRyVPPsstDRsPyEKVsA |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17174 | Y400 | Sugiyama | GOT1 | IyLLPSGRINVSGLTTKNLDyVATSIHEAVTKIQ_______ |
| P17676 | Y139 | Sugiyama | CEBPB TCF5 PP9092 | SDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCFAP |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17844 | Y425 | Sugiyama | DDX5 G17P1 HELR HLR1 | LDVEDVKFVINyDyPNSsEDyIHRIGRTARSTKtGtAytFF |
| P17844 | Y59 | Sugiyama | DDX5 G17P1 HELR HLR1 | EKLVKKKWNLDELPKFEKNFyQEHPDLARRtAQEVETYRRS |
| P17980 | T163 | Sugiyama | PSMC3 TBP1 | EKLKPGDLVGVNKDSyLILEtLPtEyDsRVKAMEVDERPtE |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18084 | Y509 | Sugiyama | ITGB5 | CSPGYLGTRCECQDGENQsVyQNLCREAEGKPLCSGRGDCS |
| P18206 | Y107 | Sugiyama | VCL | KLVQAAQMLQsDPysVPARDyLIDGSRGILsGtsDLLLTFD |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S134 | Sugiyama | PGAM1 PGAMA CDABP0006 | IWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCE |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18754 | S85 | Sugiyama | RCC1 CHC1 | IPEDVVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsV |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | Y351 | Sugiyama | NCL | FAKNDLAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKV |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P19404 | Y60 | Sugiyama | NDUFV2 | VHRDTPENNPDtPFDFTPENyKRIEAIVKNYPEGHKAAAVL |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P20810 | Y339 | Sugiyama | CAST | KAKEEKLEKCGEDDEtIPsEyRLKPATDKDGKPLLPEPEEK |
| P21127 | Y425 | Sugiyama | CDK11B CDC2L1 CDK11 PITSLREA PK58 | DYVPDSPALSPIELKQELPKyLPALQGCRsVEEFQCLNRIE |
| P21333 | Y319 | Sugiyama | FLNA FLN FLN1 | KKRAEFTVETRsAGQGEVLVyVEDPAGHQEEAKVTANNDKN |
| P21333 | Y373 | Sugiyama | FLNA FLN FLN1 | THKVTVLFAGQHIAKsPFEVyVDKsQGDASKVTAQGPGLEP |
| P21333 | Y643 | Sugiyama | FLNA FLN FLN1 | CDDKGDGsCDVRyWPQEAGEyAVHVLCNsEDIRLsPFMADI |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y142 | Sugiyama | NME2 NM23B | sVKsAEKEISLWFKPEELVDyKSCAHDWVyE__________ |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | Y131 | Sugiyama | HNRNPA2B1 HNRPA2B1 | VKKLFVGGIKEDTEEHHLRDyFEEYGKIDtIEIItDRQsGK |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P23193 | Y126 | Sugiyama | TCEA1 GTF2S TFIIS | EsTSsGNVsNRKDETNARDTyVsSFPRAPstsDsVRLKCRE |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23246 | Y527 | Sugiyama | SFPQ PSF | QVEKNMKDAKDKLEsEMEDAyHEHQANLLRQDLMRRQEELR |
| P23381 | Y316 | Sugiyama | WARS1 IFI53 WARS WRS | IFRDRtDIQCLIPCAIDQDPyFRMTRDVAPRIGYPKPALLH |
| P23396 | Y166 | Sugiyama | RPS3 OK/SW-cl.26 | RAKSMKFVDGLMIHSGDPVNyyVDTAVRHVLLRQGVLGIKV |
| P23396 | Y167 | Sugiyama | RPS3 OK/SW-cl.26 | AKSMKFVDGLMIHSGDPVNyyVDTAVRHVLLRQGVLGIKVK |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23434 | Y164 | Sugiyama | GCSH | LIKMtLsNPsELDELMsEEAyEKYIKSIEE___________ |
| P23458 | Y1034 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | JAK1 JAK1A JAK1B | EHQVKIGDFGLTKAIETDKEyyTVKDDRDSPVFWYAPECLM |
| P23458 | Y1035 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | JAK1 JAK1A JAK1B | HQVKIGDFGLTKAIETDKEyyTVKDDRDSPVFWYAPECLMQ |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23588 | Y211 | Sugiyama | EIF4B | DsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDRYDsD |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P23921 | Y74 | Sugiyama | RRM1 RR1 | VELDTLAAETAATLTTKHPDyAILAARIAVSNLHKETKKVF |
| P24534 | Y18 | Sugiyama | EEF1B2 EEF1B EF1B | ___MGFGDLKsPAGLQVLNDyLADKSYIEGYVPsQADVAVF |
| P24666 | T85 | Sugiyama | ACP1 | KRHGIPMSHVARQITKEDFAtFDyILCMDESNLRDLNRKSN |
| P24666 | Y88 | Sugiyama | ACP1 | GIPMSHVARQITKEDFAtFDyILCMDESNLRDLNRKSNQVK |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y219 | Sugiyama | ACAT1 ACAT MAT | NTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVt |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25208 | Y58 | Sugiyama | NFYB HAP3 | SMNDHEDTNGSKESFREQDIyLPIANVARIMKNAIPQTGKI |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25685 | Y5 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | ________________MGKDyyQTLGLARGAsDEEIKRAYR |
| P25685 | Y6 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | _______________MGKDyyQTLGLARGAsDEEIKRAYRR |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26639 | T56 | Sugiyama | TARS1 TARS | KEGsGDGGRAELNPWPEyIytRLEMYNILKAEHDsILAEKA |
| P26639 | Y53 | Sugiyama | TARS1 TARS | KKNKEGsGDGGRAELNPWPEyIytRLEMYNILKAEHDsILA |
| P26639 | Y633 | Sugiyama | TARS1 TARS | PFWLSPRQVMVVPVGPtCDEyAQKVRQQFHDAKFMADIDLD |
| P26640 | S301 | Sugiyama | VARS1 G7A VARS VARS2 | DLPtPPGEKKDVSGPMPDsysPRYVEAAWYPWWEQQGFFKP |
| P26640 | Y601 | Sugiyama | VARS1 G7A VARS VARS2 | VDMDFGTGAVKITPAHDQNDyEVGQRHGLEAIsIMDsRGAL |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y19 | Sugiyama | YWHAQ | __MEKTELIQKAKLAEQAERyDDMAtCMKAVtEQGAELsNE |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27540 | Y561 | Sugiyama | ARNT BHLHE2 | PLEKSDGLFAQDRDPRFsEIyHNINADQSKGISSSTVPATQ |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P28062 | Y271 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | MKEDGWVKVEsTDVSDLLHQyREANQ_______________ |
| P28066 | S6 | Sugiyama | PSMA5 | _______________MFLTRsEyDRGVNtFsPEGRLFQVEy |
| P28066 | Y185 | Sugiyama | PSMA5 | CDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSLIILKQV |
| P28066 | Y8 | Sugiyama | PSMA5 | _____________MFLTRsEyDRGVNtFsPEGRLFQVEyAI |
| P28074 | S175 | Sugiyama | PSMB5 LMPX MB1 X | SMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGSVYAY |
| P28074 | Y172 | Sugiyama | PSMB5 LMPX MB1 X | MGLSMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGSV |
| P29144 | Y118 | Sugiyama | TPP2 | KIPASWTNPSGKYHIGIKNGyDFYPKALKERIQKERKEKIW |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30040 | Y202 | Sugiyama | ERP29 C12orf8 ERP28 | KQGQDNLSSVKETQKKWAEQyLKIMGKILDQGEDFPAsEMT |
| P30040 | Y96 | Sugiyama | ERP29 C12orf8 ERP28 | LAENSASSDDLLVAEVGISDyGDKLNMELSEKYKLDKESyP |
| P30043 | Y194 | Sugiyama | BLVRB FLR SCAN | RVISKHDLGHFMLRCLttDEyDGHstyPsHQyQ________ |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y120 | Sugiyama | PEBP1 PBP PEBP | GtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsN |
| P30086 | Y125 | Sugiyama | PEBP1 PBP PEBP | DyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsNRsGDH |
| P30086 | Y169 | Sugiyama | PEBP1 PBP PEBP | FKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK__ |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y181 | Sugiyama | PEBP1 PBP PEBP | RAPVAGtCyQAEWDDyVPKLyEQLsGK______________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y264 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | CPHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVM |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y445 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLNPK |
| P30101 | Y454 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | MDAtANDVPsPyEVRGFPtIyFsPANKKLNPKKyEGGRELs |
| P30101 | Y479 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | NKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30520 | Y428 | Sugiyama | ADSS2 ADSS | WNTDISNARAFKELPVNAQNyVRFIEDELQIPVKWIGVGKs |
| P30622 | Y108 | Sugiyama | CLIP1 CYLN1 RSN | AGIVLDEPIGKNDGSVAGVRyFQCEPLKGIFTRPSKLTRKV |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1031 | Sugiyama | CPS1 | VVVNCNPETVstDFDECDKLyFEELSLERILDIYHQEACGG |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31939 | T143 | Sugiyama | ATIC PURH OK/SW-cl.86 | QIDIGGVTLLRAAAKNHARVtVVCEPEDyVVVSTEMQSSES |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | T257 | Sugiyama | STIP1 | KKKDFDtALKHYDKAKELDPtNMtyITNQAAVyFEKGDYNK |
| P31948 | Y261 | Sugiyama | STIP1 | FDtALKHYDKAKELDPtNMtyITNQAAVyFEKGDYNKCREL |
| P31948 | Y269 | Sugiyama | STIP1 | DKAKELDPtNMtyITNQAAVyFEKGDYNKCRELCEKAIEVG |
| P31948 | Y27 | Sugiyama | STIP1 | LKEKGNKALsVGNIDDALQCysEAIKLDPHNHVLysNRsAA |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y376 | Sugiyama | STIP1 | NPDLALEEKNKGNECFQKGDyPQAMKHYTEAIKRNPKDAKL |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32754 | Y105 | Sugiyama | HPD PPD | HLVKHGDGVKDIAFEVEDCDyIVQKARERGAKIMREPWVEQ |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33992 | Y212 | Sugiyama | MCM5 CDC46 | ALPRKCNTDQAGRPKCPLDPyFIMPDKCKCVDFQtLKLQEL |
| P33993 | S392 | Sugiyama | MCM7 CDC47 MCM2 | RGNINICLMGDPGVAKSQLLsyIDRLAPRSQYTTGRGssGV |
| P34896 | Y180 | Sugiyama | SHMT1 | ISATSIFFESMPYKVNPDtGyINyDQLEENARLFHPKLIIA |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P35222 | Y30 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | LDMAMEPDRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGKG |
| P35222 | Y64 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | PsLsGKGNPEEEDVDTsQVLyEWEQGFSQsFTQEQVADIDG |
| P35222 | Y86 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | WEQGFSQsFTQEQVADIDGQyAMTRAQRVRAAMFPEtLDEG |
| P35579 | Y11 | Sugiyama | MYH9 | __________MAQQAADKyLyVDKNFINNPLAQADWAAKKL |
| P35580 | Y13 | Sugiyama | MYH10 | ________MAQRTGLEDPERyLFVDRAVIYNPATQADWTAK |
| P35606 | Y193 | Sugiyama | COPB2 | GsssPNFTLEGHEKGVNCIDyysGGDKPyLIsGADDRLVKI |
| P35606 | Y824 | Sugiyama | COPB2 | AFVVEEWVKETHADLWPAKQyPLVtPNEERNVMEEGKDFQP |
| P35609 | Y385 | Sugiyama | ACTN2 | GKMVSDIAGAWQRLEQAEKGyEEWLLNEIRRLERLEHLAEK |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P36915 | Y599 | Sugiyama | GNL1 HSR1 | EGDEEtPTSAPGSSLAGRNPyALLGEDEC____________ |
| P36954 | Y111 | Sugiyama | POLR2I | HKEAVFFQSHSARAEDAMRLyyVCTAPHCGHRWTE______ |
| P36954 | Y112 | Sugiyama | POLR2I | KEAVFFQSHSARAEDAMRLyyVCTAPHCGHRWTE_______ |
| P37268 | Y220 | Sugiyama | FDFT1 | DTERANSMGLFLQKTNIIRDyLEDQQGGREFWPQEVWSRYV |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P37837 | Y206 | Sugiyama | TALDO1 TAL TALDO TALDOR | ISPFVGRILDWHVANTDKKSyEPLEDPGVKSVTKIYNYYKK |
| P37840 | Y39 | Sugiyama | SNCA NACP PARK1 | AEKTKQGVAEAAGKTKEGVLyVGsKTKEGVVHGVATVAEKT |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39687 | T143 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | CEVtNLNDyRENVFKLLPQLtyLDGyDRDDKEAPDsDAEGY |
| P39687 | Y131 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | KLENLKsLDLFNCEVtNLNDyRENVFKLLPQLtyLDGyDRD |
| P39687 | Y148 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | LNDyRENVFKLLPQLtyLDGyDRDDKEAPDsDAEGYVEGLD |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40763 | Y176 | Sugiyama | STAT3 APRF | QDLEQKMKVVENLQDDFDFNyKTLKsQGDMQDLNGNNQsVT |
| P40925 | Y210 | Sugiyama | MDH1 MDHA | tQYPDVNHAKVKLQGKEVGVyEALKDDsWLKGEFVttVQQR |
| P40926 | Y287 | Sugiyama | MDH2 | NGKEGVVECSFVKsQETECTyFsTPLLLGKKGIEKNLGIGK |
| P40926 | Y80 | Sugiyama | MDH2 | HtPGVAADLsHIEtKAAVKGyLGPEQLPDCLKGCDVVVIPA |
| P41227 | Y145 | Sugiyama | NAA10 ARD1 ARD1A TE2 | TLNFQISEVEPKyyADGEDAyAMKRDLtQMADELRRHLELK |
| P41236 | T55 | Sugiyama | PPP1R2 IPP2 | NVDEELSKKsQKWDEMNILAtyHPADKDyGLMKIDEPstPY |
| P41236 | Y56 | Sugiyama | PPP1R2 IPP2 | VDEELSKKsQKWDEMNILAtyHPADKDyGLMKIDEPstPYH |
| P41236 | Y63 | Sugiyama | PPP1R2 IPP2 | KsQKWDEMNILAtyHPADKDyGLMKIDEPstPYHsMMGDDE |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P41567 | Y54 | Sugiyama | EIF1 SUI1 | RIQQRNGRKtLttVQGIADDyDKKKLVKAFKKKFACNGtVI |
| P42025 | Y33 | Sugiyama | ACTR1B CTRN2 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALE |
| P42025 | Y38 | Sugiyama | ACTR1B CTRN2 | SGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALEGDLFI |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42166 | Y37 | Sugiyama | TMPO LAP2 | KSELVANNVTLPAGEQRKDVyVQLyLQHLTARNRPPLPAGT |
| P42166 | Y41 | Sugiyama | TMPO LAP2 | VANNVTLPAGEQRKDVyVQLyLQHLTARNRPPLPAGTNsKG |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42167 | Y37 | Sugiyama | TMPO LAP2 | KSELVANNVTLPAGEQRKDVyVQLyLQHLTARNRPPLPAGT |
| P42167 | Y41 | Sugiyama | TMPO LAP2 | VANNVTLPAGEQRKDVyVQLyLQHLTARNRPPLPAGTNSKG |
| P42224 | Y170 | Sugiyama | STAT1 | KDKVMCIEHEIKsLEDLQDEyDFKCKTLQNREHETNGVAKS |
| P42224 | Y668 | Sugiyama | STAT1 | IRNYKVMAAENIPENPLKyLyPNIDKDHAFGKYYSRPKEAP |
| P42224 | Y701 | EPSD|PSP | STAT1 | YSRPKEAPEPMELDGPKGtGyIKtELIsVsEVHPSRLQttD |
| P42229 | Y694 | SIGNOR|EPSD|PSP | STAT5A STAT5 | PKDEVFSKYYTPVLAKAVDGyVKPQIKQVVPEFVNASADAG |
| P42765 | Y198 | Sugiyama | ACAA2 | ECDKyALQSQQRWKAANDAGyFNDEMAPIEVKTKKGKQTMQ |
| P42765 | Y327 | Sugiyama | ACAA2 | AGLSLKDMDLVEVNEAFAPQyLAVERSLDLDISKTNVNGGA |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43243 | Y213 | Sugiyama | MATR3 KIAA0723 | GPsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDD |
| P43243 | Y214 | Sugiyama | MATR3 KIAA0723 | PsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDDs |
| P43243 | Y219 | Sugiyama | MATR3 KIAA0723 | VLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDDsFFGEt |
| P43243 | Y243 | Sugiyama | MATR3 KIAA0723 | RLRDGERCRDDsFFGEtsHNyHKFDsEyERMGRGPGPLQER |
| P43490 | Y188 | Sugiyama | NAMPT PBEF PBEF1 | QKKILAKyLLEtsGNLDGLEyKLHDFGyRGVSSQETAGIGA |
| P43686 | Y363 | Sugiyama | PSMC4 MIP224 TBP7 | LIFSTITSKMNLsEEVDLEDyVARPDKISGADINSICQESG |
| P45974 | Y849 | Sugiyama | USP5 ISOT | WVIYNDQKVCASEKPPKDLGyIyFyQRVAS___________ |
| P45974 | Y851 | Sugiyama | USP5 ISOT | IYNDQKVCASEKPPKDLGyIyFyQRVAS_____________ |
| P46776 | Y52 | Sugiyama | RPL27A | RGNAGGLHHHRINFDKyHPGyFGKVGMKHYHLKRNQsFCPt |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46940 | Y1478 | Sugiyama | IQGAP1 KIAA0051 | KIQTGLKKLTELGtVDPKNKyQELINDIARDIRNQRRYRQR |
| P46976 | Y332 | Sugiyama | GYG1 GYG | AQPFVSSEERKERWEQGQADyMGADSFDNIKRKLDTYLQ__ |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P47712 | Y718 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | HFNTLNNIDVIKEAMVESIEyRRQNPsRCsVsLsNVEARRF |
| P47756 | Y232 | Sugiyama | CAPZB | NIGRLVEDMENKIRstLNEIyFGKTKDIVNGLRSVQTFADK |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47756 | Y64 | Sugiyama | CAPZB | DQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKyDPPLE |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48147 | Y28 | Sugiyama | PREP PEP | DVYRDETAVQDYHGHKICDPyAWLEDPDSEQTKAFVEAQNK |
| P48637 | Y395 | Sugiyama | GSS | yGEEMVQALKQLKDSEERAsyILMEKIEPEPFENCLLRPGs |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49023 | Y118 | Sugiyama | PXN | sNPQDsVGsPCsRVGEEEHVysFPNKQKsAEPsPtVMstsL |
| P49023 | Y468 | Sugiyama | PXN | AFFGPEGFHEKDGKAYCRKDyFDMFAPKCGGCARAILENYI |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49419 | Y69 | Sugiyama | ALDH7A1 ATQ1 | EENEGVyNGSWGGRGEVIttyCPANNEPIARVRQAsVADyE |
| P49736 | Y234 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | VFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLPEAPAE |
| P49753 | Y351 | Sugiyama | ACOT2 PTE2 PTE2A | GETLPPVGVNRNRIKVTKDGyADIVDVLNsPLEGPDQKSFI |
| P50395 | Y203 | Sugiyama | GDI2 RABGDIB | DFTGHALALYRtDDyLDQPCyEtINRIKLYsEsLARYGKsP |
| P50402 | Y94 | Sugiyama | EMD EDMD STA | yDLPKKEDALLyQsKGyNDDyyEEsyFTTRTyGEPEsAGPS |
| P50402 | Y99 | Sugiyama | EMD EDMD STA | KEDALLyQsKGyNDDyyEEsyFTTRTyGEPEsAGPSRAVRQ |
| P50454 | Y245 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | MVTRSYTVGVMMMHRTGLyNyyDDEKEKLQIVEMPLAHKLs |
| P50502 | Y185 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | NAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| P50552 | Y39 | Sugiyama | VASP | GNKRWLPAGTGPQAFSRVQIyHNPTANsFRVVGRKMQPDQQ |
| P50748 | Y1794 | Sugiyama | KNTC1 KIAA0166 ROD | VSLYEHPSINQRIQNSSGTDyPDIHAAAKEIAEVNEINLEK |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P50995 | S490 | Sugiyama | ANXA11 ANX11 | RSEYKRMYGKsLyHDISGDtsGDyRKILLKICGGND_____ |
| P50995 | Y482 | Sugiyama | ANXA11 ANX11 | sEtDLLDIRSEYKRMYGKsLyHDISGDtsGDyRKILLKICG |
| P50995 | Y493 | Sugiyama | ANXA11 ANX11 | YKRMYGKsLyHDISGDtsGDyRKILLKICGGND________ |
| P51116 | S620 | Sugiyama | FXR2 FMR1L2 | GsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPsEDsLsG |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51149 | Y151 | Sugiyama | RAB7A RAB7 | NRQVATKRAQAWCySKNNIPyFEtSAKEAINVEQAFQtIAR |
| P51151 | Y150 | Sugiyama | RAB9A RAB9 | ERQVsTEEAQAWCRDNGDyPyFETSAKDATNVAAAFEEAVR |
| P51532 | Y731 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | KQDVDDEyGVsQALARGLQSyyAVAHAVTERVDKQSALMVN |
| P51532 | Y732 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | QDVDDEyGVsQALARGLQSyyAVAHAVTERVDKQSALMVNG |
| P51812 | T706 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | PQYQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTL |
| P51812 | Y707 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | QYQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLA |
| P51858 | Y23 | Sugiyama | HDGF HMG1L2 | RSNRQKEYKCGDLVFAKMKGyPHWPARIDEMPEAAVKstAN |
| P51858 | Y66 | Sugiyama | HDGF HMG1L2 | QVFFFGTHETAFLGPKDLFPyEEsKEKFGKPNKRKGFsEGL |
| P52298 | Y14 | Sugiyama | NCBP2 CBP20 PIG55 | _______MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQEK |
| P52298 | Y142 | Sugiyama | NCBP2 CBP20 PIG55 | GRQYGRGRsGGQVRDEYRQDyDAGRGGYGKLAQNQ______ |
| P52333 | S1031 | Sugiyama | JAK3 | WSFGVVLYELFTYCDKSCSPsAEFLRMMGCERDVPALCRLL |
| P52333 | Y785 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | JAK3 | VQRPSFRAVIRDLNSLIssDyELLsDPTPGALAPRDGLWNG |
| P52333 | Y809 | Sugiyama | JAK3 | sDPTPGALAPRDGLWNGAQLyACQDPTIFEERHLKyISQLG |
| P52333 | Y904 | SIGNOR|EPSD|PSP | JAK3 | VKYRGVSYGPGRQSLRLVMEyLPSGCLRDFLQRHRARLDAS |
| P52333 | Y939 | SIGNOR|EPSD|PSP | JAK3 | ARLDASRLLLYSSQICKGMEyLGSRRCVHRDLAARNILVES |
| P52333 | Y980 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | JAK3 | EAHVKIADFGLAKLLPLDKDyyVVREPGQSPIFWYAPESLS |
| P52333 | Y981 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | JAK3 | AHVKIADFGLAKLLPLDKDyyVVREPGQSPIFWYAPESLSD |
| P52565 | Y144 | Sugiyama | ARHGDIA GDIA1 | SGMKYIQHTyRKGVKIDKtDyMVGsYGPRAEEyEFLtPVEE |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P52788 | Y123 | Sugiyama | SMS | DsTGRVKRLPPIVRGGAIDRyWPTADGRLVEyDIDEVVyDE |
| P52888 | Y576 | Sugiyama | THOP1 | VLAKVDQALHTQTDADPAEEyARLCQEILGVPATPGTNMPA |
| P52907 | Y239 | Sugiyama | CAPZA1 | sNEAQtAKEFIKIIENAENEyQTAIsENyQtMSDTTFKALR |
| P52907 | Y247 | Sugiyama | CAPZA1 | EFIKIIENAENEyQTAIsENyQtMSDTTFKALRRQLPVTRT |
| P52948 | Y208 | Sugiyama | NUP98 ADAR2 | CITAMKEYESKSLEELRLEDyQANRKGPQNQVGAGTTTGLF |
| P52948 | Y627 | Sugiyama | NUP98 ADAR2 | NsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDENHQQ |
| P52948 | Y741 | Sugiyama | NUP98 ADAR2 | EIENNsYHMHPAGIILtKVGyytIPsMDDLAKITNEKGECI |
| P52948 | Y742 | Sugiyama | NUP98 ADAR2 | IENNsYHMHPAGIILtKVGyytIPsMDDLAKITNEKGECIV |
| P52948 | Y848 | Sugiyama | NUP98 ADAR2 | PTDKTSRCLIKsPDRLADINyEGRLEAVSRKQGAQFKEyRP |
| P53041 | Y422 | Sugiyama | PPP5C PPP5 | VsCQFGPDVTKAFLEENNLDyIIRSHEVKAEGYEVAHGGRC |
| P53396 | Y659 | Sugiyama | ACLY | TGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISRTTD |
| P53611 | Y26 | Sugiyama | RABGGTB GGTB | KDVIIKsDAPDTLLLEKHADyIASYGSKKDDYEYCMSEYLR |
| P53634 | Y438 | Sugiyama | CTSC CPPI | SGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAt |
| P53990 | Y43 | Sugiyama | IST1 KIAA0174 | KLLEKKKTELAQKARKEIADyLAAGKDERARIRVEHIIRED |
| P54105 | Y214 | Sugiyama | CLNS1A CLCI ICLN | QsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQFEDAD |
| P54105 | Y38 | Sugiyama | CLNS1A CLCI ICLN | RQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEY |
| P54577 | S386 | Sugiyama | YARS1 YARS | sRLDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGL |
| P54577 | Y292 | Sugiyama | YARS1 YARS | KSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLKNS |
| P54577 | Y388 | Sugiyama | YARS1 YARS | LDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGLVQ |
| P54578 | Y436 | Sugiyama | USP14 TGT | GYYDLQAVLTHQGRSssSGHyVSWVKRKQDEWIKFDDDKVs |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P55263 | Y129 | Sugiyama | ADK | IDKFGEILKRKAAEAHVDAHyyEQNEQPTGTCAACITGDNR |
| P55327 | Y136 | Sugiyama | TPD52 | LQELKQNIAKGWQDVTATSAyKKTSETLSQAGQKASAAFSS |
| P55786 | Y295 | Sugiyama | NPEPPS PSA | AEQGKFALEVAAKTLPFYKDyFNVPYPLPKIDLIAIADFAA |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P58546 | Y21 | Sugiyama | MTPN | MCDKEFMWALKNGDLDEVKDyVAKGEDVNRtLEGGRKPLHY |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60174 | Y48 | Sugiyama | TPI1 TPI | tLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQNCy |
| P60228 | Y116 | Sugiyama | EIF3E EIF3S6 INT6 | EDPETTRQMQSTRDGRMLFDyLADKHGFRQEYLDTLYRYAK |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y218 | Sugiyama | ACTB | ysFtttAEREIVRDIKEKLCyVALDFEQEMAtAAssssLEK |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60900 | Y159 | Sugiyama | PSMA6 PROS27 | ILIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFL |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P61081 | T176 | Sugiyama | UBE2M UBC12 | NRRLFEQNVQRSMRGGyIGstyFERCLK_____________ |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61158 | Y16 | Sugiyama | ACTR3 ARP3 | _____MAGRLPACVVDCGtGytKLGYAGNTEPQFIIPSCIA |
| P61158 | Y400 | Sugiyama | ACTR3 ARP3 | GGSMLASTPEFYQVCHTKKDyEEIGPsICRHNPVFGVMs__ |
| P61163 | Y241 | Sugiyama | ACTR1A CTRN1 | ACYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPEL |
| P61163 | Y33 | Sugiyama | ACTR1A CTRN1 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALE |
| P61163 | Y38 | Sugiyama | ACTR1A CTRN1 | SGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALEGDIFI |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61353 | Y77 | Sugiyama | RPL27 | MGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVN |
| P61586 | Y156 | Sugiyama | RHOA ARH12 ARHA RHO12 | QEPVKPEEGRDMANRIGAFGyMECsAKTKDGVREVFEMAtR |
| P61604 | T79 | Sugiyama | HSPE1 | EIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDILGK |
| P61604 | Y100 | Sugiyama | HSPE1 | KVVLDDKDyFLFRDGDILGKyVD__________________ |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62191 | Y439 | Sugiyama | PSMC1 | FKKSKENVLyKKQEGtPEGLyL___________________ |
| P62195 | Y148 | Sugiyama | PSMC5 SUG1 | PNKVDPLVSLMMVEKVPDSTyEMIGGLDKQIKEIKEVIELP |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y20 | Sugiyama | YWHAE | _MDDREDLVyQAKLAEQAERyDEMVESMKKVAGMDVELTVE |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62312 | Y72 | Sugiyama | LSM6 | VNGQLKNKyGDAFIRGNNVLyIstQKRRM____________ |
| P62495 | Y345 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | NLDIMRYVLHCQGTEEEKILyLTPEQEKDKSHFTDKETGQE |
| P62633 | S121 | Sugiyama | CNBP RNF163 ZNF9 | CGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRCG |
| P62633 | Y120 | Sugiyama | CNBP RNF163 ZNF9 | NCGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRC |
| P62633 | Y75 | Sugiyama | CNBP RNF163 ZNF9 | YRCGESGHLAKDCDLQEDACyNCGRGGHIAKDCKEPKRERE |
| P62714 | Y80 | Sugiyama | PPP2CB | GQFHDLMELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLL |
| P62714 | Y86 | Sugiyama | PPP2CB | MELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLLVALKVR |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62745 | Y156 | Sugiyama | RHOB ARH6 ARHB | QEPVRTDDGRAMAVRIQAyDyLECSAKTKEGVREVFETATR |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62873 | Y145 | Sugiyama | GNB1 | NLKTREGNVRVSRELAGHTGyLsCCRFLDDNQIVTSSGDTT |
| P62879 | Y145 | Sugiyama | GNB2 | SLKTREGNVRVsRELPGHtGyLSCCRFLDDNQIITSSGDTT |
| P62888 | Y62 | Sugiyama | RPL30 | KAKLVILANNCPALRKsEIEyyAMLAKtGVHHysGNNIELG |
| P62888 | Y63 | Sugiyama | RPL30 | AKLVILANNCPALRKsEIEyyAMLAKtGVHHysGNNIELGt |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63092 | Y190 | Sugiyama | GNAS GNAS1 GSP | QLIDCAQYFLDKIDVIKQADyVPSDQDLLRCRVLTSGIFET |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y211 | Sugiyama | YWHAZ | LAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63173 | Y41 | Sugiyama | RPL38 | KSVKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLP |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | T52 | Sugiyama | RPS21 | IQMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRL |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y218 | Sugiyama | ACTG1 ACTG | ysFtttAEREIVRDIKEKLCyVALDFEQEMAtAAssssLEK |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67775 | Y80 | Sugiyama | PPP2CA | GQFHDLMELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLL |
| P67775 | Y86 | Sugiyama | PPP2CA | MELFRIGGKsPDtNyLFMGDyVDRGYYSVETVTLLVALKVR |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68104 | Y418 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | DAAIVDMVPGKPMCVEsFSDyPPLGRFAVRDMRQtVAVGVI |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | Y103 | Sugiyama | TUBA1B | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| P68363 | Y224 | Sugiyama | TUBA1B | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68366 | Y103 | Sugiyama | TUBA4A TUBA1 | YRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDPVLDRIR |
| P68366 | Y224 | Sugiyama | TUBA4A TUBA1 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| P68400 | Y323 | Sugiyama | CSNK2A1 CK2A1 | KLLRYDHQSRLTAREAMEHPyFytVVKDQARMGSSSMPGGS |
| P68400 | Y325 | Sugiyama | CSNK2A1 CK2A1 | LRYDHQSRLTAREAMEHPyFytVVKDQARMGSSSMPGGStP |
| P78356 | Y117 | Sugiyama | PIP4K2B PIP5K2B | EYCPMVFRNLRERFGIDDQDyQNsVTRSAPINSDSQGRCGT |
| P78536 | Y433 | Sugiyama | ADAM17 CSVP TACE | AEHDPDGLAECAPNEDQGGKyVMYPIAVSGDHENNKMFSNC |
| P80303 | Y350 | Sugiyama | NUCB2 NEFA | PDsWEtLDQQQFFtEEELKEyENIIALQENELKKKADELQK |
| P80303 | Y389 | Sugiyama | NUCB2 NEFA | QKQKEELQRQHDQLEAQKLEyHQVIQQMEQKKLQQGIPPSG |
| P80303 | Y53 | Sugiyama | NUCB2 NEFA | KVQNIHPVESAKIEPPDTGLyyDEyLKQVIDVLETDKHFRE |
| P80303 | Y54 | Sugiyama | NUCB2 NEFA | VQNIHPVESAKIEPPDTGLyyDEyLKQVIDVLETDKHFREK |
| P80303 | Y57 | Sugiyama | NUCB2 NEFA | IHPVESAKIEPPDTGLyyDEyLKQVIDVLETDKHFREKLQK |
| P84103 | Y13 | Sugiyama | SRSF3 SFRS3 SRP20 | ________MHRDsCPLDCKVyVGNLGNNGNKtELERAFGyy |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| P98175 | Y694 | Sugiyama | RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 | QPISSLRDDERREsAtADAGyAILEKKGALAERQHTsMDLP |
| P98179 | Y117 | Sugiyama | RBM3 RNPL | HGRGRSYSRGGGDQGYGSGRyyDsRPGGyGyGyGRSRDYNG |
| P99999 | S48 | Sugiyama | CYCS CYC | KTGPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEY |
| Q00341 | T39 | Sugiyama | HDLBP HBP VGL | LVPQQIKVAtLNsEEEsDPPtyKDAFPPLPEKAACLESAQE |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00610 | Y899 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LAKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACV |
| Q00610 | Y900 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACVA |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00653 | Y247 | Sugiyama | NFKB2 LYT10 | NLKISRMDKTAGSVRGGDEVyLLCDKVQKDDIEVRFYEDDE |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q00839 | Y654 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | LKMKGNFTLPEVAECFDEITyVELQKEEAQKLLEQYKEESK |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | Y135 | Sugiyama | SET | EALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKE |
| Q01105 | Y140 | Sugiyama | SET | LTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNE |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q01518 | Y43 | Sugiyama | CAP1 CAP | HtsDMHRGyADsPsKAGAAPyVQAFDSLLAGPVAEyLKISK |
| Q01518 | Y58 | Sugiyama | CAP1 CAP | AGAAPyVQAFDSLLAGPVAEyLKISKEIGGDVQKHAEMVHT |
| Q02809 | Y344 | Sugiyama | PLOD1 LLH PLOD | NHEQHHKAQVEEFLAQHGsEyQsVKLVGPEVRMANADARNM |
| Q02809 | Y434 | Sugiyama | PLOD1 LLH PLOD | LWSNFWGALSADGYYARSEDyVDIVQGRRVGVWNVPYISNI |
| Q02878 | Y115 | Sugiyama | RPL6 TXREB1 | PVGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQ |
| Q04446 | Y657 | Sugiyama | GBE1 | RVGTALPGKFKIVLDSDAAEyGGHQRLDHSTDFFSEAFEHN |
| Q04637 | Y958 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | LLTTIGKDLDFEKAKPRMDQyFNQMEKIIKEKKTSSRIRFM |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y20 | Sugiyama | YWHAH YWHA1 | _MGDREQLLQRARLAEQAERyDDMAsAMKAVtELNEPLsNE |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05209 | T81 | Sugiyama | PTPN12 | KNRYKDILPFDHSRVKLTLKtPsQDSDyINANFIKGVYGPK |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06323 | S31 | Sugiyama | PSME1 IFI5111 | QAKVDVFREDLCTKtENLLGsyFPKKIsELDAFLKEPALNE |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07157 | T1067 | Sugiyama | TJP1 ZO1 | EKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRVPMy |
| Q07157 | Y1191 | Sugiyama | TJP1 ZO1 | LRPEAQPHPsAGPKPAEsKQyFEQysRsyEQVPPQGFTSRA |
| Q07157 | Y1354 | Sugiyama | TJP1 ZO1 | LKPPEDIVRSNHyDPEEDEEyyRKQLsyFDRRsFENKPPAH |
| Q07157 | Y1355 | Sugiyama | TJP1 ZO1 | KPPEDIVRSNHyDPEEDEEyyRKQLsyFDRRsFENKPPAHI |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07889 | Y1008 | Sugiyama | SOS1 | KRFFENLNPMGNSMEKEFTDyLFNKSLEIEPRNPKPLPRFP |
| Q07890 | Y1006 | Sugiyama | SOS2 | RRFFENLNPMGSASEKEFTDyLFNKSLEIEPRNCKQPPRFP |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08211 | Y132 | Sugiyama | DHX9 DDX9 LKP NDH2 | PLPPHLALKAENNsEVGAsGyGVPGPTWDRGANLKDYYSRK |
| Q08AD1 | Y661 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | RDYTVSLDsDMDDASKFLQDyDIRTGNTREALsPCPsTVsT |
| Q08J23 | Y38 | Sugiyama | NSUN2 SAKI TRM4 | DAEDGAEGGGKRGEAGWEGGyPEIVKENKLFEHyyQELKIV |
| Q09028 | Y154 | Sugiyama | RBBP4 RBAP48 | PQNPCIIATKtPssDVLVFDyTKHPsKPDPsGECNPDLRLR |
| Q12792 | Y53 | Sugiyama | TWF1 PTK9 | ENEQLVIGSYSQPSDSWDKDyDsFVLPLLEDKQPCYILFRL |
| Q12846 | Y115 | Sugiyama | STX4 STX4A | REIRLQLKAIEPQKEEADENyNsVNtRMRKTQHGVLSQQFV |
| Q12904 | Y24 | Sugiyama | AIMP1 EMAP2 SCYE1 | NDAVLKRLEQKGAEADQIIEyLKQQVSLLKEKAILQATLRE |
| Q12931 | Y498 | Sugiyama | TRAP1 HSP75 HSPC5 | GQLtsLsEyASRMRAGtRNIyyLCAPNRHLAEHsPyyEAMK |
| Q12931 | Y513 | Sugiyama | TRAP1 HSP75 HSPC5 | GtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDE |
| Q12931 | Y514 | Sugiyama | TRAP1 HSP75 HSPC5 | tRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDEL |
| Q13085 | Y306 | Sugiyama | ACACA ACAC ACC1 ACCA | YEKGYVKDVDDGLQAAEEVGyPVMIKASEGGGGKGIRKVNN |
| Q13098 | Y172 | Sugiyama | GPS1 COPS1 CSN1 | YKGNSIKESIRRGHDDLGDHyLDCGDLSNALKCYSRARDYC |
| Q13200 | Y469 | Sugiyama | PSMD2 TRAP2 | GIVNSGVRNECDPALALLsDyVLHNSNTMRLGSIFGLGLAY |
| Q13228 | T38 | Sugiyama | SELENBP1 SBP | AMKGPREEIVyLPCIyRNtGtEAPDyLATVDVDPKsPQyCQ |
| Q13228 | Y28 | Sugiyama | SELENBP1 SBP | CGPGySTPLEAMKGPREEIVyLPCIyRNtGtEAPDyLATVD |
| Q13228 | Y33 | Sugiyama | SELENBP1 SBP | STPLEAMKGPREEIVyLPCIyRNtGtEAPDyLATVDVDPKs |
| Q13228 | Y43 | Sugiyama | SELENBP1 SBP | REEIVyLPCIyRNtGtEAPDyLATVDVDPKsPQyCQVIHRL |
| Q13228 | Y56 | Sugiyama | SELENBP1 SBP | tGtEAPDyLATVDVDPKsPQyCQVIHRLPMPNLKDELHHSG |
| Q13242 | Y17 | Sugiyama | SRSF9 SFRS9 SRP30C | ____MsGWADERGGEGDGRIyVGNLPTDVREKDLEDLFyKY |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13263 | Y755 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | GGTLDLTLIRARLQEKLsPPyssPQEFAQDVGRMFKQFNKL |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | Y125 | Sugiyama | G3BP1 G3BP | LRRFMQtFVLAPEGsVANKFyVHNDIFRyQDEVFGGFVtEP |
| Q13283 | Y19 | Sugiyama | G3BP1 G3BP | __MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNss |
| Q13283 | Y363 | Sugiyama | G3BP1 G3BP | FIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGFV |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13330 | Y11 | Sugiyama | MTA1 | __________MAANMYRVGDyVyFENSSSNPYLIRRIEELN |
| Q13330 | Y13 | Sugiyama | MTA1 | ________MAANMYRVGDyVyFENSSSNPYLIRRIEELNKT |
| Q13371 | Y15 | Sugiyama | PDCL PHLOP1 PhLP1 | ______MTTLDDKLLGEKLQyyysssEDEDsDHEDKDRGRC |
| Q13371 | Y16 | Sugiyama | PDCL PHLOP1 PhLP1 | _____MTTLDDKLLGEKLQyyysssEDEDsDHEDKDRGRCA |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | Y70 | Sugiyama | PDAP1 HASPP28 | DPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDIENPNRVA |
| Q13464 | Y603 | Sugiyama | ROCK1 | RELQERNRILENSKSQTDKDyyQLQAILEAERRDRGHDSEM |
| Q13464 | Y604 | Sugiyama | ROCK1 | ELQERNRILENSKSQTDKDyyQLQAILEAERRDRGHDSEMI |
| Q13464 | Y851 | Sugiyama | ROCK1 | QYRGNEGQMRELQDQLEAEQyFSTLyKTQVKELKEEIEEKN |
| Q13509 | Y106 | Sugiyama | TUBB3 TUBB4 | RPDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECEN |
| Q13526 | Y92 | Sugiyama | PIN1 | SWRQEKITRTKEEALELINGyIQKIKSGEEDFEsLAsQFSD |
| Q13546 | Y384 | Sugiyama | RIPK1 RIP RIP1 | EHPQEENEPSLQSKLQDEANyHLyGsRMDRQTKQQPRQNVA |
| Q13561 | S211 | Sugiyama | DCTN2 DCTN50 | SGGKttGtPPDssLVtyELHsRPEQDKFSQAAKVAELEKRL |
| Q13561 | Y207 | Sugiyama | DCTN2 DCTN50 | SKGGSGGKttGtPPDssLVtyELHsRPEQDKFSQAAKVAEL |
| Q13561 | Y81 | Sugiyama | DCTN2 DCTN50 | RVGTKGLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQ |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13573 | Y433 | Sugiyama | SNW1 SKIIP SKIP | NQSKGMDSGFAGGEDEIyNVyDQAWRGGKDMAQsIyRPSKN |
| Q13601 | Y287 | Sugiyama | KRR1 HRB2 | tPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKAKQA |
| Q13619 | Y259 | Sugiyama | CUL4A | TNCLYAAEGQRLMQEREVPEyLNHVSKRLEEEGDRVITYLD |
| Q13620 | Y413 | Sugiyama | CUL4B KIAA0695 | TNRLYAAEGQKLMQEREVPEyLHHVNKRLEEEADRLITYLD |
| Q13642 | Y149 | Sugiyama | FHL1 SLIM1 | CSNCKQVIGtGSFFPKGEDFyCVtCHETKFAKHCVKCNKAI |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13885 | Y106 | Sugiyama | TUBB2A TUBB2 | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14157 | Y858 | Sugiyama | UBAP2L KIAA0144 NICE4 | PFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATT |
| Q14192 | Y97 | Sugiyama | FHL2 DRAL SLIM3 | DKPFAAKEDQLLCTDCySNEySSKCQECKKTIMPGTRKMEY |
| Q14204 | Y2881 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | IDREKAMSRPILYSNWLSKDyIPVDQEELRDyVKARLKVFY |
| Q14204 | Y2892 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | LYSNWLSKDyIPVDQEELRDyVKARLKVFYEEELDVPLVLF |
| Q14204 | Y4357 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | VDMISKMLKMQMLEDEDDLAyAETEKKTRtDstsDGRPAWM |
| Q14247 | Y141 | Sugiyama | CTTN EMS1 | FGGKFGVQMDRVDQsAVGFEyQGKtEKHAsQKDyssGFGGK |
| Q14247 | Y178 | Sugiyama | CTTN EMS1 | FGGKyGVQADRVDKsAVGFDyQGKTEKHESQRDYSKGFGGK |
| Q14247 | Y215 | Sugiyama | CTTN EMS1 | FGGKyGIDKDKVDKsAVGFEyQGKtEKHESQKDyVKGFGGK |
| Q14247 | Y289 | Sugiyama | CTTN EMS1 | FGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDySKGFGGK |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y545 | Sugiyama | CTTN EMS1 | IDDGWWRGVCKGRyGLFPANyVELRQ_______________ |
| Q14257 | Y122 | Sugiyama | RCN2 ERC55 | AKQQFVEYDKNSDDTVTWDEyNIQMyDRVIDFDENtALDDA |
| Q14257 | Y303 | Sugiyama | RCN2 ERC55 | LsEEEILENPDLFLtsEAtDyGRQLHDDyFyHDEL______ |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14258 | Y245 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | NRQQDVRMTANRKVEQLQQEytEMKALLDASETTSTRKIKE |
| Q14566 | Y598 | Sugiyama | MCM6 | FARQFKPKISKESEDFIVEQyKHLRQRDGSGVTKSSWRITV |
| Q14566 | Y810 | Sugiyama | MCM6 | LTQAGLKGstEGsEsYEEDPyLVVNPNyLLED_________ |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14671 | Y83 | Sugiyama | PUM1 KIAA0099 PUMH1 | SPVPGSIGVAGRsQDDAMVDyFFQRQHGEQLGGGGsGGGGy |
| Q14677 | Y114 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | SERVVTSAREHIyDLRSLENyHFVDEHGKDQGINIRQKVKE |
| Q14696 | Y58 | Sugiyama | MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369 | PGTPDESTPPPRKKKKDIRDyNDADMARLLEQWEKDDDIEE |
| Q14697 | Y341 | Sugiyama | GANAB G2AN KIAA0088 | TWVDISSNTAGKTLFGKMMDyLQGSGETPQTDVRWMSETGI |
| Q14764 | Y365 | Sugiyama | MVP LRP | DEEKVSHQAGDHWLIRGPLEyVPSAKVEVVEERQAIPLDEN |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q14CX7 | Y19 | Sugiyama | NAA25 C12orf30 MDM20 NAP1 | __MATRGHVQDPNDRRLRPIyDyLDNGNNKMAIQQADKLLK |
| Q14CX7 | Y21 | Sugiyama | NAA25 C12orf30 MDM20 NAP1 | MATRGHVQDPNDRRLRPIyDyLDNGNNKMAIQQADKLLKKH |
| Q15019 | Y211 | Sugiyama | SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2 | ERERLKKRILDEIEEHNIKIyHLPDAEsDEDEDFKEQtRLL |
| Q15024 | Y13 | Sugiyama | EXOSC7 KIAA0116 RRP42 | ________MASVTLSEAEKVyIVHGVQEDLRVDGRGCEDYR |
| Q15029 | Y161 | Sugiyama | EFTUD2 KIAA0031 SNRP116 | GKTCFVDCLIEQTHPEIRKRyDQDLCyTDILFTEQERGVGI |
| Q15029 | Y167 | Sugiyama | EFTUD2 KIAA0031 SNRP116 | DCLIEQTHPEIRKRyDQDLCyTDILFTEQERGVGIKSTPVT |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15056 | Y86 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | sIRsVRLVRDKDTDKFKGFCyVEFDEVDsLKEALtyDGALL |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15293 | Y147 | Sugiyama | RCN1 RCN | YDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKM |
| Q15293 | Y148 | Sugiyama | RCN1 RCN | DRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKML |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15398 | Y323 | Sugiyama | DLGAP5 DLG7 KIAA0008 | GKNSFAPKDFMFQPLDGLKTyQVTPMtPRsANAFLtPsytW |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | S451 | Sugiyama | SF3A1 SAP114 | IGLLDPRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAE |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15555 | Y268 | Sugiyama | MAPRE2 RP1 | NEQVHsLKLALEGVEKERDFyFGKLREIELLCQEHGQENDD |
| Q15642 | Y590 | Sugiyama | TRIP10 CIP4 STOT STP | MEEDKGDGWTRVRRKEGGEGyVPtsyLRVTLN_________ |
| Q15642 | Y595 | Sugiyama | TRIP10 CIP4 STOT STP | GDGWTRVRRKEGGEGyVPtsyLRVTLN______________ |
| Q15691 | Y217 | Sugiyama | MAPRE1 | MQQVNVLKLtVEDLEKERDFyFGKLRNIELICQENEGENDP |
| Q15717 | Y200 | EPSD|PSP | ELAVL1 HUR | TVKFAANPNQNKNVALLsQLyHsPARRFGGPVHHQAQRFRF |
| Q15717 | Y63 | EPSD|PSP | ELAVL1 HUR | IGEVESAKLIRDKVAGHSLGyGFVNyVTAKDAERAINTLNG |
| Q15717 | Y68 | EPSD|PSP | ELAVL1 HUR | SAKLIRDKVAGHSLGyGFVNyVTAKDAERAINTLNGLRLQs |
| Q15796 | Y151 | Sugiyama | SMAD2 MADH2 MADR2 | LWRWPDLHSHHELKAIENCEyAFNLKKDEVCVNPyHyQRVE |
| Q15813 | Y58 | Sugiyama | TBCE | GVEWDNPERGKHDGSHEGtVyFKCRHPTGGSFIRPNKVNFG |
| Q15910 | Y244 | EPSD|PSP | EZH2 KMT6 | FEAISSMFPDKGTAEELKEKyKELTEQQLPGALPPECtPNI |
| Q16143 | Y39 | Sugiyama | SNCB | AEKTKQGVTEAAEKTKEGVLyVGsKTREGVVQGVASVAEKT |
| Q16576 | Y153 | Sugiyama | RBBP7 RBAP46 | PQNPHIIATKtPssDVLVFDyTKHPAKPDPsGECNPDLRLR |
| Q16851 | Y89 | Sugiyama | UGP2 UGP1 | KGPSVDWGKIQRPPEDSIQPyEKIKARGLPDNISsVLNKLV |
| Q1KMD3 | Y214 | Sugiyama | HNRNPUL2 HNRPUL2 | DGERRGVKRQRDEKDEHGRAyyEFREEAYHsRsKsPLPPEE |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY69 | Y913 | Sugiyama | ALDH1L2 | FGGVKQSGFGKDLGEEALNEyLKTKTVTLEY__________ |
| Q49A26 | Y548 | Sugiyama | GLYR1 HIBDL NDF NP60 NPAC | NEVYKRAKALDQsDNDMSAVyRAYIH_______________ |
| Q53EL6 | S76 | Sugiyama | PDCD4 H731 | NAKAKRRLRKNssRDsGRGDsVsDsGsDALRSGLtVPtsPK |
| Q53H82 | Y121 | Sugiyama | LACTB2 CGI-83 | IKKLPRNPQREEIIGNGEQQyVyLKDGDVIKTEGATLRVLY |
| Q53H82 | Y123 | Sugiyama | LACTB2 CGI-83 | KLPRNPQREEIIGNGEQQyVyLKDGDVIKTEGATLRVLYTP |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5JTH9 | Y1253 | Sugiyama | RRP12 KIAA0690 | YKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQGQF |
| Q5JWF2 | Y833 | Sugiyama | GNAS GNAS1 | QLIDCAQYFLDKIDVIKQADyVPSDQDLLRCRVLTSGIFET |
| Q5R372 | Y591 | Sugiyama | RABGAP1L HHL KIAA0471 | DSAQESVITRDIHRTFPAHDyFKDTGGDGQESLYKICKAYS |
| Q5SW79 | Y532 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | EEVEARKMIDKVFGVDDNQDyNRPVINEKHKDLIKDWALss |
| Q5T035 | Y67 | Sugiyama | FAM120A2P C9orf129 | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPIN |
| Q5U5X0 | Y96 | Sugiyama | LYRM7 C5orf31 MZM1L | TDHNTLKLVPRKDLLVENVPyCDAPTQKQ____________ |
| Q5VT52 | Y1090 | Sugiyama | RPRD2 KIAA0460 HSPC099 | sCLDLPDSTEEKGAPIETLGyHsASNRRMsGEPIQTVESIR |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VTE0 | Y418 | Sugiyama | EEF1A1P5 EEF1AL3 | DAAIVDMVPGKPMCVEsFSDyPPLGRFAVRDMRQtVAVGVI |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6L8Q7 | Y235 | Sugiyama | PDE12 | sLsPssPsssWtEtDVEERVytPSNADIGLRLKLHCTPGDG |
| Q6NVY1 | Y247 | Sugiyama | HIBCH | EDLLALKsPSKENIAsVLENyHtESKIDRDKSFILEEHMDK |
| Q6P1L8 | Y51 | Sugiyama | MRPL14 MRPL32 RPML32 | AIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKVGD |
| Q6PEY2 | Y224 | Sugiyama | TUBA3E | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y918 | Sugiyama | POTEE A26C1A POTE2 | YRFTTMAEREIVRDIKEKLCyVALDFEQEMAtAAssssLEK |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UN15 | Y453 | Sugiyama | FIP1L1 FIP1 RHE | HLPGSAPsWPSLVDTSKQWDyyARREKDRDRERDRDRERDR |
| Q6UN15 | Y454 | Sugiyama | FIP1L1 FIP1 RHE | LPGSAPsWPSLVDTSKQWDyyARREKDRDRERDRDRERDRD |
| Q6UUV9 | Y50 | Sugiyama | CRTC1 KIAA0616 MECT1 TORC1 WAMTP1 | EVMKDLSLTRAARLQLQKSQyLQLGPSRGQyYGGsLPNVNQ |
| Q6UVK1 | Y1166 | Sugiyama | CSPG4 MCSP | DTAVLHLDTNLDIRSGDEVHyHVTAGPRWGQLVRAGQPATA |
| Q71RC2 | Y425 | Sugiyama | LARP4 PP13296 | SRNFPAERHNPTVTGHQEQtyLQKETSTLQVEQNGDYGRGR |
| Q71U36 | Y103 | Sugiyama | TUBA1A TUBA3 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| Q71U36 | Y224 | Sugiyama | TUBA1A TUBA3 | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7RTV0 | Y70 | Sugiyama | PHF5A | NyGsyQGRCVICGGPGVSDAyyCKECTIQEKDRDGCPKIVN |
| Q7Z2W4 | Y299 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | IsHRAsLEDAPVDDLtRKFtyLGsQDRARPPsGsSKATDLG |
| Q7Z3K3 | Y33 | Sugiyama | POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 | EELEPWQKISDVIEDsVVEDyNsVDKTTTVSVSQQPVSAPV |
| Q7Z4V5 | Y18 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | ___MPHAFKPGDLVFAKMKGyPHWPARIDDIADGAVKPPPN |
| Q86TX2 | Y289 | Sugiyama | ACOT1 CTE1 | GETLPPVGVNRNRIKVTKDGyADIVDVLNsPLEGPDQKSFI |
| Q86UU0 | Y266 | Sugiyama | BCL9L DLNB11 | HLANTAAEAVLQGRADSILAyHQQNVPRAKLDQAPKVPPTP |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q86VS8 | Y171 | Sugiyama | HOOK3 | MTAIQELMSKEsPVSAGNDAyVDLDRQLKKTTEELNEALSA |
| Q86XP3 | Y160 | Sugiyama | DDX42 | ERKNVKGIRDDIEEEDDQEAyFRYMAENPtAGVVQEEEEDN |
| Q8IVM0 | S143 | Sugiyama | CCDC50 C3orf6 | EEKKRKKHFPEFPATRAyADsyyyEDGGMKPRVMKEAVSTP |
| Q8IVM0 | Y144 | Sugiyama | CCDC50 C3orf6 | EKKRKKHFPEFPATRAyADsyyyEDGGMKPRVMKEAVSTPS |
| Q8IVM0 | Y146 | Sugiyama | CCDC50 C3orf6 | KRKKHFPEFPATRAyADsyyyEDGGMKPRVMKEAVSTPSRM |
| Q8IWZ3 | Y1269 | Sugiyama | ANKHD1 KIAA1085 MASK VBARP PP2500 | NVEHRAKTGLTPLMEAASGGyAEVGRVLLDKGADVNAPPVP |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8IZP0 | S22 | Sugiyama | ABI1 SSH3BP1 | AELQMLLEEEIPSGKRALIEsyQNLTRVADyCENNyIQATD |
| Q8N0Y7 | S134 | Sugiyama | PGAM4 PGAM3 | IWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYE |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N128 | Y139 | Sugiyama | FAM177A1 C14orf24 | EKIASVLGISTPKYQYAIDEyYRMKKEEEEEEEENRMsEEA |
| Q8N1G4 | Y257 | Sugiyama | LRRC47 KIAA1185 | LRDKRLEKMVSGCQTRSILEyLRVGGRGGGKGKGRAEGSEK |
| Q8N3D4 | Y1362 | Sugiyama | EHBP1L1 | EPPPSPGEEAGLQRFQDtsQyVCAELQALEQEQRQIDGRAA |
| Q8N5P1 | Y97 | Sugiyama | ZC3H8 ZC3HDC8 | sDNDICsQEsEDNFAKELQQyIQAREMANAAQPEESTKKEG |
| Q8N6H7 | Y278 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | QAADAKKQAEESMVASMRLAyQELQIDRKKEEKKLQNLEGK |
| Q8N6T3 | Y175 | Sugiyama | ARFGAP1 ARF1GAP | sVtAssDKAFEDWLNDDLGsyQGAQGNRyVGFGNtPPPQKK |
| Q8N7H5 | Y311 | Sugiyama | PAF1 PD2 | IAREYNWNVKNKASKGyEENyFFIFREGDGVyyNELETRVR |
| Q8N806 | Y376 | Sugiyama | UBR7 C14orf130 | PLMDTLSSMNRVQQVELICEyNDLKTELKDYLKRFADEGTV |
| Q8NBF2 | Y39 | Sugiyama | NHLRC2 | TSLEYALLDAVTQQEKDSLVyQyLQKVDGWEQDLSVPEFPE |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NBS9 | Y289 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | RDGKKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSE |
| Q8NFI4 | Y185 | Sugiyama | ST13P5 FAM10A5 | NAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| Q8NI08 | Y526 | Sugiyama | NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993 | RVENTLNIHEDLDKVKLIEyyLTKNKEGPQVSENLQKTELS |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TD19 | T522 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | YSWGCGEyGRLGLDSEEDyytPQKVDVPKALIIVAVQCGCD |
| Q8TD19 | Y52 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PSASQGPRAGGGAAEQEELHyIPIRVLGRGAFGEAtLyRRT |
| Q8TD19 | Y520 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | EVYSWGCGEyGRLGLDSEEDyytPQKVDVPKALIIVAVQCG |
| Q8TD19 | Y845 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PDsPsPLsAAFsEsEKDTLPyEELQGLKVAsEAPLEHKPQV |
| Q8TEW0 | Y388 | Sugiyama | PARD3 PAR3 PAR3A | QLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAPRL |
| Q8WTS6 | Y146 | Sugiyama | SETD7 KIAA1717 KMT7 SET7 SET9 | GGSLVGEVNEDGEMTGEKIAyVYPDERTALYGKFIDGEMIE |
| Q8WVJ2 | Y145 | Sugiyama | NUDCD2 | ERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK________ |
| Q8WVV9 | Y34 | Sugiyama | HNRNPLL HNRPLL SRRF BLOCK24 | EDREYESQAKRLKTEEGEIDysAEEGENRREAtPRGGGDGG |
| Q8WXF1 | Y275 | Sugiyama | PSPC1 PSP1 | YHKEREQPPRFAQPGTFEFEyASRWKALDEMEKQQREQVDR |
| Q92598 | Y614 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | VELPIEANLVWQLGKDLLNMyIETEGKMIMQDKLEKERNDA |
| Q92598 | Y641 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MIMQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQD |
| Q92796 | S615 | Sugiyama | DLG3 KIAA1232 | GLSDDYYGAKNLKGQEDAILsYEPVTRQEIHYARPVIILGP |
| Q92878 | Y1162 | Sugiyama | RAD50 | EINKIIRDLWRSTYRGQDIEyIEIRSDADENVSASDKRRNY |
| Q92890 | Y219 | Sugiyama | UFD1 UFD1L | EPERQVQHEEstEGEADHsGyAGELGFRAFsGsGNRLDGKK |
| Q92900 | Y1112 | Sugiyama | UPF1 KIAA0221 RENT1 | SYLGDEFKsQIDVALsQDstyQGERAyQHGGVtGLsQy___ |
| Q92900 | Y1118 | Sugiyama | UPF1 KIAA0221 RENT1 | FKsQIDVALsQDstyQGERAyQHGGVtGLsQy_________ |
| Q92905 | Y203 | Sugiyama | COPS5 CSN5 JAB1 | LGAFRTYPKGYKPPDEGPsEyQtIPLNKIEDFGVHCKQYYA |
| Q92945 | Y644 | Sugiyama | KHSRP FUBP2 | EyyKKIGQQPQQPGAPPQQDytKAWEEYYKKQAQVATGGGP |
| Q92947 | Y398 | Sugiyama | GCDH | ALDIARQARDMLGGNGISDEyHVIRHAMNLEAVNTYEGTHD |
| Q93052 | Y297 | Sugiyama | LPP | PPPGLQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPty |
| Q93052 | Y300 | Sugiyama | LPP | GLQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPtyGQQ |
| Q93052 | Y301 | Sugiyama | LPP | LQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPtyGQQG |
| Q96AE4 | T629 | Sugiyama | FUBP1 | PDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ_____ |
| Q96AE4 | Y58 | Sugiyama | FUBP1 | ARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKV |
| Q96AE4 | Y625 | Sugiyama | FUBP1 | PGGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ_ |
| Q96AE4 | Y626 | Sugiyama | FUBP1 | GGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ__ |
| Q96B26 | Y13 | Sugiyama | EXOSC8 OIP2 RRP43 | ________MAAGFKTVEPLEyyRRFLKENCRPDGRELGEFR |
| Q96C19 | T84 | Sugiyama | EFHD2 SWS1 | DLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKDMEKMFKQy |
| Q96C90 | S32 | Sugiyama | PPP1R14B PLCB3N PNG | LAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGPVRR |
| Q96C90 | Y29 | Sugiyama | PPP1R14B PLCB3N PNG | GAALAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGP |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96FW1 | Y26 | Sugiyama | OTUB1 OTB1 OTU1 HSPC263 | PQQQKQEPLGsDsEGVNCLAyDEAIMAQQDRIQQEIAVQNP |
| Q96G03 | Y177 | Sugiyama | PGM2 MSTP006 | CAGIMItAsHNPKQDNGYKVyWDNGAQIIsPHDKGISQAIE |
| Q96GA3 | Y301 | Sugiyama | LTV1 C6orf93 | AELEGSIQVDSNRLQEVLNDyyKEKAENCVKLNTLEPLEDQ |
| Q96GA3 | Y66 | Sugiyama | LTV1 C6orf93 | IDNEERRAEQRKyGVFFDDDyDyLQHLKEPSGPSELIPSST |
| Q96GA3 | Y68 | Sugiyama | LTV1 C6orf93 | NEERRAEQRKyGVFFDDDyDyLQHLKEPSGPSELIPSSTFS |
| Q96HR8 | Y285 | Sugiyama | NAF1 | KGIKIKETMYFAPSMKDFTQyIFTEKLKQDKGSDASWKNDQ |
| Q96LC7 | Y597 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SIGLEC10 SLG2 UNQ477/PRO940 | RRTQTETPRPRFSRHstILDyINVVPTAGPLAQKRNQKATP |
| Q96LC7 | Y667 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SIGLEC10 SLG2 UNQ477/PRO940 | PEPKSSTQAPESQESQEELHyATLNFPGVRPRPEARMPKGT |
| Q96LC7 | Y691 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SIGLEC10 SLG2 UNQ477/PRO940 | NFPGVRPRPEARMPKGTQADyAEVKFQ______________ |
| Q96QC0 | Y512 | Sugiyama | PPP1R10 CAT53 FB19 PNUTS | GILQELFLNKESPHEPDPEPyEPIPPKLIPLDEECSMDETP |
| Q96QK1 | S500 | Sugiyama | VPS35 MEM3 TCCCTA00141 | DPEDFADEQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAG |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q99426 | Y107 | Sugiyama | TBCB CG22 CKAP1 | VIDHsGARLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKR |
| Q99426 | Y114 | Sugiyama | TBCB CG22 CKAP1 | RLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyN |
| Q99426 | Y98 | Sugiyama | TBCB CG22 CKAP1 | PVDDGCRIHVIDHsGARLGEyEDVSRVEKytIsQEAyDQRQ |
| Q99459 | S463 | Sugiyama | CDC5L KIAA0432 PCDC5RP | PLRDKLNINPEDGMADysDPsyVKQMERESREHLRLGLLGL |
| Q99459 | Y459 | Sugiyama | CDC5L KIAA0432 PCDC5RP | PGRtPLRDKLNINPEDGMADysDPsyVKQMERESREHLRLG |
| Q99459 | Y464 | Sugiyama | CDC5L KIAA0432 PCDC5RP | LRDKLNINPEDGMADysDPsyVKQMERESREHLRLGLLGLP |
| Q99470 | Y187 | Sugiyama | SDF2 | GRPISGQKEVHGMAQPSQNNyWKAMEGIFMKPSELLKAEAH |
| Q99471 | Y90 | Sugiyama | PFDN5 MM1 PFD5 | MYVPGKLHDVEHVLIDVGtGyyVEKTAEDAKDFFKRKIDFL |
| Q99471 | Y91 | Sugiyama | PFDN5 MM1 PFD5 | YVPGKLHDVEHVLIDVGtGyyVEKTAEDAKDFFKRKIDFLT |
| Q99497 | T140 | Sugiyama | PARK7 | GSKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPGT |
| Q99497 | Y141 | Sugiyama | PARK7 | SKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPGTS |
| Q99536 | T243 | Sugiyama | VAT1 | ASKHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIVMDP |
| Q99536 | Y240 | Sugiyama | VAT1 | TASASKHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIV |
| Q99536 | Y245 | Sugiyama | VAT1 | KHEALKENGVTHPIDyHttDyVDEIKKISPKGVDIVMDPLG |
| Q99543 | Y137 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | KHHPDKRKAAGEPIKEGDNDyFTCITKAYEMLSDPVKRRAF |
| Q99543 | Y274 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | TRAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAE |
| Q99613 | Y884 | Sugiyama | EIF3C EIF3S8 | GsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRRGGY |
| Q99615 | Y351 | Sugiyama | DNAJC7 TPR2 TTC2 | YLRRAQCYMDtEQyEEAVRDyEKVyQTEKTKEHKQLLKNAQ |
| Q99615 | Y50 | Sugiyama | DNAJC7 TPR2 TTC2 | TFKEQGNAYYAKKDYNEAyNyytKAIDMCPKNASYYGNRAA |
| Q99733 | Y55 | Sugiyama | NAP1L4 NAP2 | PRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQV |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y390 | Sugiyama | ACO2 | KEGWPLDIRVGLIGSCTNssyEDMGRSAAVAKQALAHGLKC |
| Q99798 | Y513 | Sugiyama | ACO2 | PEIVTALAIAGTLKFNPEtDyLTGtDGKKFRLEAPDADELP |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99961 | Y57 | Sugiyama | SH3GL1 CNSA1 SH3D2B | EKKVDVTSKAVTEVLARTIEyLQPNPAsRAKLTMLNTVSKI |
| Q99962 | Y57 | Sugiyama | SH3GL2 CNSA2 SH3D2A | ERKVDVTSRAVMEIMTKTIEyLQPNPAsRAKLSMINTMsKI |
| Q9BPX3 | Y929 | Sugiyama | NCAPG CAPG NYMEL3 | QDATLTTTTFQNEDEKNKEVyMtPLRGVKATQASKSTQLKT |
| Q9BQE3 | Y103 | Sugiyama | TUBA1C TUBA6 | yRQLFHPEQLItGKEDAANNyARGHYTIGKEIIDLVLDRIR |
| Q9BQE3 | Y224 | Sugiyama | TUBA1C TUBA6 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BQG0 | Y355 | Sugiyama | MYBBP1A P160 | EHVCTAKLPKQFKFAPEMDDyVGTFLEGCQDDPERQLAVLV |
| Q9BRK5 | Y342 | Sugiyama | SDF4 CAB45 PSEC0034 | MIAVADENQNHHLEPEEVLKysEFFTGSKLVDYARsVHEEF |
| Q9BRS2 | Y83 | Sugiyama | RIOK1 RIO1 | YDDDDDDWDWDEGVGKLAKGyVWNGGsNPQANRQTSDSSSA |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BSJ8 | Y822 | Sugiyama | ESYT1 FAM62A KIAA0747 MBC2 | IYMERAEDLPLRKGTKHLsPyAtLTVGDssHKTKTISQTSA |
| Q9BSU3 | Y145 | Sugiyama | NAA11 ARD1B ARD2 | TLNFQISEVEPKyyADGEDAyAMKRDLSQMADELRRQMDLK |
| Q9BTC8 | Y11 | Sugiyama | MTA3 KIAA1266 | __________MAANMYRVGDyVyFENSSSNPYLIRRIEELN |
| Q9BTC8 | Y13 | Sugiyama | MTA3 KIAA1266 | ________MAANMYRVGDyVyFENSSSNPYLIRRIEELNKT |
| Q9BTT0 | Y92 | Sugiyama | ANP32E | SDNIISGGLEVLAEKCPNLTyLNLSGNKIKDLsTVEALQNL |
| Q9BU89 | Y290 | Sugiyama | DOHH HLRC1 | RESCEVALDMyEHETGRAFQyADGLEQLRGAPS________ |
| Q9BUP3 | Y62 | Sugiyama | HTATIP2 CC3 TIP30 | GLFSKVTLIGRRKLTFDEEAyKNVNQEVVDFEKLDDYASAF |
| Q9BVA1 | Y106 | Sugiyama | TUBB2B | RPDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESES |
| Q9BXS5 | Y418 | Sugiyama | AP1M1 CLTNM | IEKSGYQALPWVRYITQNGDyQLRtQ_______________ |
| Q9BY32 | Y45 | Sugiyama | ITPA C20orf37 My049 OK/SW-cl.9 | QILGDKFPCTLVAQKIDLPEyQGEPDEIsIQKCQEAVRQVQ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BZZ5 | Y28 | Sugiyama | API5 MIG8 | YRNyGILADATEQVGQHKDAyQVILDGVKGGTKEKRLAAQF |
| Q9C0C2 | Y961 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GSRAAEPQEQEFGKSAWIRDyssGGsSRtLDAQDRsFGtRP |
| Q9C0D5 | Y327 | Sugiyama | TANC1 KIAA1728 | IMPRPNsVAAtsstKLEDLSyLDGQRNAPLRtsIRLPWHNt |
| Q9GZT8 | Y175 | Sugiyama | NIF3L1 ALS2CR1 MDS015 My018 | PSKAPNyPTEGNHRVEFNVNytQDLDKVMSAVKGIDGVsVT |
| Q9GZY8 | Y35 | Sugiyama | MFF C2orf33 AD030 AD033 GL004 | SRAAFPsPTAAEMAEISRIQyEMEyTEGISQRMRVPEKLKV |
| Q9GZY8 | Y39 | Sugiyama | MFF C2orf33 AD030 AD033 GL004 | FPsPTAAEMAEISRIQyEMEyTEGISQRMRVPEKLKVAPPN |
| Q9H0A0 | Y963 | Sugiyama | NAT10 ALP KIAA1709 | EFQEKHKKEVGKLKsMDLSEyIIRGDDEEWNEVLNKAGPNA |
| Q9H0D6 | Y764 | Sugiyama | XRN2 | DLTQNTVVSINFKDPQFAEDyIFKAVMLPGARKPAAVLKPS |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H3G5 | Y205 | Sugiyama | CPVL VLP PSEC0124 UNQ197/PRO223 | QFFQIFPEYKNNDFyVTGESyAGKYVPAIAHLIHSLNPVRE |
| Q9H4A3 | Y545 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | SFDLERDVPEDVAQEMVESGyVCEGDHKTMAKAIKDRVSLI |
| Q9H4F8 | Y407 | Sugiyama | SMOC1 | FKRYVKKKAKPKKCARRFtDyCDLNKDKVISLPELKGCLGV |
| Q9H4M9 | Y339 | Sugiyama | EHD1 PAST PAST1 CDABP0131 | PNVFGKESKKKELVNNLGEIyQKIEREHQIsPGDFPsLRKM |
| Q9H6T3 | Y90 | Sugiyama | RPAP3 | KESSKKTREENTKNRIKsyDyEAWAKLDVDRILDELDKDDs |
| Q9H788 | Y131 | Sugiyama | SH2D4A PPP1R38 SH2A | EEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKDIWKKVAE |
| Q9H814 | Y154 | Sugiyama | PHAX RNUXA | LGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDLDKE |
| Q9H814 | Y309 | Sugiyama | PHAX RNUXA | FLNLLKNtPsISEEQIKDIFyIENQKEYENKKAARKRRTQV |
| Q9H814 | Y57 | Sugiyama | PHAX RNUXA | GDsAMRAFQNTAtACAPVSHyRAVESVDSSEESFSDSDDDS |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9HAV0 | Y145 | Sugiyama | GNB4 | NLKTREGNVRVsRELPGHtGyLSCCRFLDDSQIVTSSGDTT |
| Q9HC35 | Y226 | Sugiyama | EML4 C2orf2 EMAPL4 | PKVTKTADKHKDVIINQEGEyIKMFMRGRPItMFIPSDVDN |
| Q9HC38 | Y192 | Sugiyama | GLOD4 C17orf25 CGI-150 My027 | NLLGMKIYEKDEEKQRALLGyADNQCKLELQGVKGGVDHAA |
| Q9HCC0 | Y520 | Sugiyama | MCCC2 MCCB | ADEAALKEPIIKKFEEEGNPyySsARVWDDGIIDPADTRLV |
| Q9HCC0 | Y521 | Sugiyama | MCCC2 MCCB | DEAALKEPIIKKFEEEGNPyySsARVWDDGIIDPADTRLVL |
| Q9HCE1 | Y980 | Sugiyama | MOV10 KIAA1631 | NLLQGLsKLsPstsGPHsHDyLPQEREGEGGLsLQVEPEWR |
| Q9HCN8 | Y81 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSGSGQQSVtGVEAsDDANSyWRIRGGSEGGCPRGSPVRCG |
| Q9NNW7 | Y70 | Sugiyama | TXNRD2 KIAA1652 TRXR2 | GGLACAKEAAQLGRKVAVVDyVEPSPQGTRWGLGGTCVNVG |
| Q9NQC3 | Y889 | Sugiyama | RTN4 KIAA0886 NOGO My043 SP1507 | DEFPTLISSKTDSFSKLAREyTDLEVSHKSEIANAPDGAGS |
| Q9NQR4 | Y202 | Sugiyama | NIT2 CUA002 | TTGPAHWELLQRSRAVDNQVyVAtAsPARDDKASYVAWGHS |
| Q9NQW7 | Y588 | Sugiyama | XPNPEP1 XPNPEPL XPNPEPL1 | QTKMIDVDSLTDKECDWLNNyHLtCRDVIGKELQKQGRQEA |
| Q9NRX4 | Y113 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | ysMAyGPAQHAISTEKIKAKyPDyEVtWANDGy________ |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9NY65 | Y103 | Sugiyama | TUBA8 TUBAL2 | YRQLFHPEQLItGKEDAANNyARGHYTVGKESIDLVLDRIR |
| Q9NY65 | Y224 | Sugiyama | TUBA8 TUBAL2 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| Q9NYF8 | Y219 | Sugiyama | BCLAF1 BTF KIAA0164 | IDEFNKssAtsGDIWPGLsAyDNsPRsPHsPsPIAtPPSQS |
| Q9NYF8 | Y408 | Sugiyama | BCLAF1 BTF KIAA0164 | EsGKQKFNDsEGDDtEEtEDyRQFRKsVLADQGKsFATAsH |
| Q9NYU2 | Y1516 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | PMTKEPKLEAAVRIVPEWQDyDQEIKQLQIRFQKEKETGAL |
| Q9NYU2 | Y449 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | IEGLSLHNVLKLNIQPsEADyAVDIRSPAISWVNNLEVDSR |
| Q9NYU2 | Y966 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | LVMKVDALLsAQPKGDPRIEyQFFEDRHSAIKLRPKEGETY |
| Q9NZB2 | Y418 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPIN |
| Q9NZB2 | Y9 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | ____________MGVQGFQDyIEKHCPsAVVPVELQKLARG |
| Q9NZD8 | Y10 | Sugiyama | SPG21 ACP33 BM-019 GL010 | ___________MGEIKVSPDyNWFRGTVPLKKIIVDDDDSK |
| Q9P0J1 | Y381 | Sugiyama | PDP1 PDP PPM2C | SIDLQKRVIESGPDQLNDNEytKFIPPNYHTPPYLTAEPEV |
| Q9P0P0 | Y152 | Sugiyama | RNF181 HSPC238 | RDKARKQQQQHRLENLHGAMyt___________________ |
| Q9P270 | Y293 | Sugiyama | SLAIN2 KIAA1458 | NDVTDVQILARMQEESLRQEyAATTSRRSSGSSCNSTRRGt |
| Q9P2J5 | Y507 | Sugiyama | LARS1 KIAA1352 LARS | VQDVKKTIQKKMIDAGDALIyMEPEKQVMSRSSDECVVALC |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UBS4 | Y222 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | VNEERTLEVEIEPGVRDGMEyPFIGEGEPHVDGEPGDLRFR |
| Q9UBS4 | Y74 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | PDRNPDDPQAQEKFQDLGAAyEVLsDSEKRKQyDTyGEEGL |
| Q9UFG5 | Y63 | Sugiyama | C19orf25 | EDPPVPFRMMEDAEAPGEQLyQQSRAYVAANQRLQQAGNVL |
| Q9UGI8 | Y126 | Sugiyama | TES | INTVtyEWAPPVQNQALARQyMQMLPKEKQPVAGsEGAQYR |
| Q9UHD1 | Y26 | Sugiyama | CHORDC1 CHP1 | YNRGCGQRFDPETNsDDACtyHPGVPVFHDALKGWSCCKRR |
| Q9UHI6 | Y659 | Sugiyama | DDX20 DP103 GEMIN3 | RVPVLASSsQsGDsEsDSDSySSRTSSQSKGNKsyLEGssD |
| Q9UHI6 | Y711 | Sugiyama | DDX20 DP103 GEMIN3 | DDRIsLEQPPNGsDtPNPEKyQEsPGIQMKTRLKEGASQRA |
| Q9UHR4 | Y380 | Sugiyama | BAIAP2L1 IRTKS | SFAQGDVITLLIPEEKDGWLyGEHDVSKARGWFPssYTKLL |
| Q9UHR5 | Y196 | Sugiyama | SAP30BP HCNGP HTRG HTRP | ELGTNYPKDMFDPHGWSEDSyyEALAKAQKIEMDKLEKAKK |
| Q9UHR5 | Y197 | Sugiyama | SAP30BP HCNGP HTRG HTRP | LGTNYPKDMFDPHGWSEDSyyEALAKAQKIEMDKLEKAKKE |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UII2 | Y58 | Sugiyama | ATP5IF1 ATPI ATPIF1 | GsIREAGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEI |
| Q9UJU6 | Y16 | Sugiyama | DBNL CMAP SH3P7 PP5423 | _____MAANLSRNGPALQEAyVRVVtEKsPtDWALFTyEGN |
| Q9UKJ3 | Y90 | Sugiyama | GPATCH8 GPATC8 KIAA0553 | IPIVVKYDVMGMGRMEMELDyAEDATERRRVLEVEKEDTEE |
| Q9UKS6 | Y374 | Sugiyama | PACSIN3 | sDEEsPRKAATGVRVRALyDyAGQEADELsFRAGEELLKMS |
| Q9UKV3 | Y1086 | Sugiyama | ACIN1 ACINUS KIAA0670 | RTALHGVKWPQSNPKFLCADyAEQDELDyHRGLLVDRPsEt |
| Q9UKV3 | Y1094 | Sugiyama | ACIN1 ACINUS KIAA0670 | WPQSNPKFLCADyAEQDELDyHRGLLVDRPsEtKTEEQGIP |
| Q9UL25 | Y150 | Sugiyama | RAB21 KIAA0118 | VGNKIDLEKERHVsIQEAESyAESVGAKHYHTSAKQNKGIE |
| Q9ULX6 | Y435 | Sugiyama | AKAP8L NAKAP NAKAP95 HRIHFB2018 | EHFKYVGTKLPKQTADFLQEyVTNKTKKTEELRKTVEDLDG |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UN86 | T21 | Sugiyama | G3BP2 KIAA0660 | MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSSYV |
| Q9UN86 | Y19 | Sugiyama | G3BP2 KIAA0660 | __MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSS |
| Q9UNP9 | Y300 | Sugiyama | PPIE CYP33 | AQGSKDGKPKQKVIIADCGEyV___________________ |
| Q9UNZ2 | S205 | Sugiyama | NSFL1C UBXN2C | KLWKsGFsLDNGELRSyQDPsNAQFLEsIRRGEVPAELRRL |
| Q9UNZ2 | Y167 | Sugiyama | NSFL1C UBXN2C | PRPFAGGGYRLGAAPEEEsAyVAGEKRQHssQDVHVVLKLW |
| Q9UNZ2 | Y201 | Sugiyama | NSFL1C UBXN2C | HVVLKLWKsGFsLDNGELRSyQDPsNAQFLEsIRRGEVPAE |
| Q9UPQ0 | Y179 | Sugiyama | LIMCH1 KIAA1102 | QMRKDTDDIEsPKRSIRDsGyIDCWDsERsDsLsPPRHGRD |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | Y1049 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | CPGsLsLCAGVKsstPPGEsyFGVssLQLKGQsQtsPDHRs |
| Q9Y230 | Y446 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | IKRVysLFLDEsRSTQYMKEyQDAFLFNELKGEtMDTS___ |
| Q9Y262 | T44 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | DMHTGDPKQDLAyERQyEQQtyQVIPEVIKNFIQYFHKTVS |
| Q9Y262 | Y415 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | GDKMLRMQKGDPQVyEELFsysCPKFLSPVVPNYDNVHPNY |
| Q9Y265 | Y438 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | KINGKDSIEKEHVEEIsELFyDAKSSAKILADQQDKYMK__ |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2B0 | Y71 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKE |
| Q9Y2B0 | Y92 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ARsEAHLtELLEEICDRMKEyGEQIDPstHRKNYVRVVGRN |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2W2 | Y236 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | GRKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDD |
| Q9Y394 | S328 | Sugiyama | DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448 | ITNKMGKKRIENFKSGVDADssyFKIFKTKHD_________ |
| Q9Y3D8 | Y78 | Sugiyama | AK6 CINAP AD-004 CGI-137 | EDRVVDELDNQMREGGVIVDyHGCDFFPERWFHIVFVLRTD |
| Q9Y3E1 | Y22 | Sugiyama | HDGFL3 HDGF2 HDGFRP3 CGI-142 | ARPRPREYKAGDLVFAKMKGyPHWPARIDELPEGAVKPPAN |
| Q9Y3F4 | T109 | Sugiyama | STRAP MAWD UNRIP | VSGDELMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDL |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y3F4 | Y261 | Sugiyama | STRAP MAWD UNRIP | GGEDFKLyKyDyNsGEELEsyKGHFGPIHCVRFSPDGELyA |
| Q9Y3P9 | Y619 | Sugiyama | RABGAP1 HSPC094 | ESPQDSAITRDINRTFPAHDyFKDTGGDGQDSLYKICKAYS |
| Q9Y3S2 | Y253 | Sugiyama | ZNF330 NOA36 | LKFGRQTGGEEGDGASGYDAyWKNLSSDKYGDTSYHDEEED |
| Q9Y450 | Y58 | Sugiyama | HBS1L HBS1 KIAA1038 | AQFIYSRRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQ |
| Q9Y490 | Y1893 | Sugiyama | TLN1 KIAA1027 TLN | TKsNtsPEELGPLANQLTsDyGRLAsEAKPAAVAAENEEIG |
| Q9Y4H2 | Y625 | Sugiyama | IRS2 | FsGsAGRLCPsCPAssPKVAyHPyPEDyGDIEIGsHRssss |
| Q9Y4H2 | Y632 | Sugiyama | IRS2 | LCPsCPAssPKVAyHPyPEDyGDIEIGsHRssssNLGADDG |
| Q9Y4K4 | Y20 | Sugiyama | MAP4K5 | _MEAPLRPAADILRRNPQQDyELVQRVGsGTYGDVYKARNV |
| Q9Y5K5 | Y168 | Sugiyama | UCHL5 UCH37 AD-019 CGI-70 | MFEFDTKTSAKEEDAFHFVSyVPVNGRLyELDGLREGPIDL |
| Q9Y5L4 | Y73 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | KPGGsLDNSEQKCIAMCMDRyMDAWNtVsRAYNSRLQRERA |
| Q9Y5Q8 | Y182 | Sugiyama | GTF3C5 CDABP0017 | QELPLYIPPPIFSRLDAPVDyFyRPETQHREGYNNPPIsGE |
| Q9Y5Q8 | Y184 | Sugiyama | GTF3C5 CDABP0017 | LPLYIPPPIFSRLDAPVDyFyRPETQHREGYNNPPIsGENL |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y617 | Y101 | Sugiyama | PSAT1 PSA | GQFSAVPLNLIGLKAGRCADyVVTGAWSAKAAEEAKKFGTI |
| Q9Y639 | S224 | Sugiyama | NPTN SDFR1 SDR1 | RINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDITGHK |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y692 | Y337 | Sugiyama | GMEB1 | VKKVLDNRRNQVEQGEEQFLytLTDLERQLEEQKKQGQDHR |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
| Q9Y6Y8 | Y935 | Sugiyama | SEC23IP MSTP053 | KQVVEAEKVVEsPDFsKDEDyLGKVGMLNGGRRIDYVLQEK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.110223e-16 | 15.955 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.110223e-16 | 15.955 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.110223e-16 | 15.955 | 1 | 1 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.110223e-16 | 15.955 | 1 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.110223e-16 | 15.955 | 1 | 0 |
| Signal Transduction | R-HSA-162582 | 6.459167e-12 | 11.190 | 1 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.176016e-10 | 9.662 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.802615e-10 | 9.420 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.904018e-10 | 9.408 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.712036e-10 | 9.243 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.172127e-09 | 8.931 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.703530e-09 | 8.431 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.413616e-09 | 8.193 | 1 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.691415e-08 | 7.772 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.520223e-08 | 7.599 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.236767e-07 | 6.908 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.236767e-07 | 6.908 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.514893e-07 | 6.599 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.428051e-07 | 6.465 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.188615e-07 | 6.087 | 1 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.248129e-06 | 5.904 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.505796e-06 | 5.822 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.663272e-06 | 5.779 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.840156e-06 | 5.735 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.033820e-06 | 5.692 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.641600e-06 | 5.578 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.007918e-06 | 5.522 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.529715e-06 | 5.452 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.280515e-06 | 5.369 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.621004e-06 | 5.017 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.099643e-05 | 4.959 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.348242e-05 | 4.870 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.501695e-05 | 4.823 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.582294e-05 | 4.801 | 1 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.825914e-05 | 4.739 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.232257e-05 | 4.651 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.351794e-05 | 4.629 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.491272e-05 | 4.604 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.473391e-05 | 4.607 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.773937e-05 | 4.557 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.358467e-05 | 4.474 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.998853e-05 | 4.398 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.243689e-05 | 4.372 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.549733e-05 | 4.256 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 9.549563e-05 | 4.020 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.549563e-05 | 4.020 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.549563e-05 | 4.020 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.017437e-04 | 3.992 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.140485e-04 | 3.943 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 1.474940e-04 | 3.831 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.514257e-04 | 3.820 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.587935e-04 | 3.799 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.778402e-04 | 3.750 | 1 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.811132e-04 | 3.742 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.730725e-04 | 3.762 | 1 | 1 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.853720e-04 | 3.732 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.910297e-04 | 3.719 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.167410e-04 | 3.664 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.479335e-04 | 3.606 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.649846e-04 | 3.577 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.649846e-04 | 3.577 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.649846e-04 | 3.577 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.843232e-04 | 3.546 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.843232e-04 | 3.546 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.843232e-04 | 3.546 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.857689e-04 | 3.544 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.243943e-04 | 3.489 | 1 | 1 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.683567e-04 | 3.434 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.683567e-04 | 3.434 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.721290e-04 | 3.429 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.164222e-04 | 3.380 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.304032e-04 | 3.366 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.304032e-04 | 3.366 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.688046e-04 | 3.329 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.688046e-04 | 3.329 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.711399e-04 | 3.327 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.688046e-04 | 3.329 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.257191e-04 | 3.279 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.332534e-04 | 3.273 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.332534e-04 | 3.273 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.540124e-04 | 3.184 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.275671e-04 | 3.202 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.166140e-04 | 3.210 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.391000e-04 | 3.131 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.832908e-04 | 3.106 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.030480e-04 | 3.095 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.197421e-04 | 3.036 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.097492e-03 | 2.960 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.170379e-03 | 2.932 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.170379e-03 | 2.932 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.073697e-03 | 2.969 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.280435e-03 | 2.893 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.293844e-03 | 2.888 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.315342e-03 | 2.881 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.409499e-03 | 2.851 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.448385e-03 | 2.839 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.481500e-03 | 2.829 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.647770e-03 | 2.783 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.688264e-03 | 2.773 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.745144e-03 | 2.758 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.848911e-03 | 2.733 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.070689e-03 | 2.684 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.070689e-03 | 2.684 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.070689e-03 | 2.684 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.072067e-03 | 2.684 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.070689e-03 | 2.684 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.182574e-03 | 2.661 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.182574e-03 | 2.661 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.231256e-03 | 2.651 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.271395e-03 | 2.644 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.274557e-03 | 2.643 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.574554e-03 | 2.589 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.759083e-03 | 2.559 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.798205e-03 | 2.553 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.798205e-03 | 2.553 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.798205e-03 | 2.553 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.154936e-03 | 2.501 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.068208e-03 | 2.513 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.154936e-03 | 2.501 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.154936e-03 | 2.501 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.154936e-03 | 2.501 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.952475e-03 | 2.530 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.102122e-03 | 2.508 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.239514e-03 | 2.490 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.446337e-03 | 2.463 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.446337e-03 | 2.463 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.446337e-03 | 2.463 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.446337e-03 | 2.463 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.628586e-03 | 2.440 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.813028e-03 | 2.419 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.700513e-03 | 2.432 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 3.628586e-03 | 2.440 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 3.628586e-03 | 2.440 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.059487e-03 | 2.392 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.658683e-03 | 2.437 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 4.559520e-03 | 2.341 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.559520e-03 | 2.341 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.052196e-03 | 2.297 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.573904e-03 | 2.254 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.588735e-03 | 2.253 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.588735e-03 | 2.253 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.588735e-03 | 2.253 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 5.588735e-03 | 2.253 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.682254e-03 | 2.245 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.721817e-03 | 2.242 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.998080e-03 | 2.222 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.713996e-03 | 2.173 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.713996e-03 | 2.173 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.042995e-03 | 2.152 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.713996e-03 | 2.173 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.036909e-03 | 2.219 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.042995e-03 | 2.152 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 6.713996e-03 | 2.173 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.484980e-03 | 2.188 | 1 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.603350e-03 | 2.119 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.785905e-03 | 2.109 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.785905e-03 | 2.109 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.864902e-03 | 2.104 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.933103e-03 | 2.101 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.526510e-03 | 2.069 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.980033e-03 | 2.047 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.093189e-02 | 1.961 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.093189e-02 | 1.961 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.093189e-02 | 1.961 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.093189e-02 | 1.961 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.093189e-02 | 1.961 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.093189e-02 | 1.961 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.093189e-02 | 1.961 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.093189e-02 | 1.961 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.093189e-02 | 1.961 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.093189e-02 | 1.961 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.093189e-02 | 1.961 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.093189e-02 | 1.961 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.093189e-02 | 1.961 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.093189e-02 | 1.961 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.093189e-02 | 1.961 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.093189e-02 | 1.961 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.093189e-02 | 1.961 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.093189e-02 | 1.961 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.093189e-02 | 1.961 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.093189e-02 | 1.961 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.093189e-02 | 1.961 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.093189e-02 | 1.961 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.093189e-02 | 1.961 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.093189e-02 | 1.961 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.093189e-02 | 1.961 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.093189e-02 | 1.961 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.093189e-02 | 1.961 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 9.243895e-03 | 2.034 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 9.243895e-03 | 2.034 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.439198e-03 | 2.025 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.064424e-02 | 1.973 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.255635e-03 | 2.034 | 1 | 1 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.439198e-03 | 2.025 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.064424e-02 | 1.973 | 1 | 1 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.064424e-02 | 1.973 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.213206e-02 | 1.916 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.213206e-02 | 1.916 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.213206e-02 | 1.916 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.370528e-02 | 1.863 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.370528e-02 | 1.863 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.370528e-02 | 1.863 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.302797e-02 | 1.885 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.122470e-02 | 1.950 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.370528e-02 | 1.863 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.370528e-02 | 1.863 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.151198e-02 | 1.939 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.151198e-02 | 1.939 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.151198e-02 | 1.939 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.370528e-02 | 1.863 | 1 | 1 |
| RET signaling | R-HSA-8853659 | 1.225645e-02 | 1.912 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.187451e-02 | 1.925 | 1 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.179177e-02 | 1.928 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.382666e-02 | 1.859 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.489184e-02 | 1.827 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.536189e-02 | 1.814 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.550606e-02 | 1.809 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.637702e-02 | 1.786 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.687434e-02 | 1.773 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.709989e-02 | 1.767 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.709989e-02 | 1.767 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.729544e-02 | 1.762 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.729544e-02 | 1.762 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.729544e-02 | 1.762 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.891733e-02 | 1.723 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.891733e-02 | 1.723 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.891733e-02 | 1.723 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.001544e-02 | 1.699 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.006665e-02 | 1.698 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.015789e-02 | 1.696 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.015789e-02 | 1.696 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.018698e-02 | 1.695 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.061398e-02 | 1.686 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.081228e-02 | 1.682 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.081228e-02 | 1.682 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.120632e-02 | 1.674 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.143400e-02 | 1.669 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.159131e-02 | 1.666 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.174494e-02 | 1.663 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.174494e-02 | 1.663 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.278286e-02 | 1.642 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.482720e-02 | 1.605 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.694347e-02 | 1.570 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.912988e-02 | 1.536 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.125278e-02 | 1.505 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.556157e-02 | 1.592 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.138466e-02 | 1.503 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.443109e-02 | 1.612 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.138466e-02 | 1.503 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.912988e-02 | 1.536 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.694347e-02 | 1.570 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.443109e-02 | 1.612 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.556157e-02 | 1.592 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.054594e-02 | 1.515 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.054594e-02 | 1.515 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.054594e-02 | 1.515 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.694347e-02 | 1.570 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.694347e-02 | 1.570 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.524483e-02 | 1.598 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.482720e-02 | 1.605 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.443109e-02 | 1.612 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.605284e-02 | 1.584 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.244044e-02 | 1.489 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.244044e-02 | 1.489 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.244044e-02 | 1.489 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.244044e-02 | 1.489 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.248185e-02 | 1.488 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.370606e-02 | 1.472 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.390741e-02 | 1.470 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.559980e-02 | 1.449 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.578373e-02 | 1.446 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.609239e-02 | 1.443 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.609239e-02 | 1.443 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.840073e-02 | 1.416 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.854196e-02 | 1.414 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.854196e-02 | 1.414 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.900074e-02 | 1.409 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.981493e-02 | 1.400 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.981493e-02 | 1.400 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.981493e-02 | 1.400 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.981493e-02 | 1.400 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.981493e-02 | 1.400 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.105312e-02 | 1.387 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 4.105312e-02 | 1.387 | 1 | 1 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.105312e-02 | 1.387 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.112468e-02 | 1.386 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.127379e-02 | 1.384 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.127379e-02 | 1.384 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.275935e-02 | 1.369 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.301965e-02 | 1.366 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.301965e-02 | 1.366 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.301965e-02 | 1.366 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.301965e-02 | 1.366 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.301965e-02 | 1.366 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.362425e-02 | 1.360 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.737478e-02 | 1.324 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.895461e-02 | 1.310 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.895461e-02 | 1.310 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.348384e-02 | 1.272 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.348384e-02 | 1.272 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.348384e-02 | 1.272 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 6.383425e-02 | 1.195 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.383425e-02 | 1.195 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 6.383425e-02 | 1.195 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 5.168164e-02 | 1.287 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.447696e-02 | 1.264 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.447696e-02 | 1.264 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.732455e-02 | 1.242 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.022294e-02 | 1.220 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.920868e-02 | 1.160 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.222510e-02 | 1.282 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.447696e-02 | 1.264 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.732455e-02 | 1.242 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.920868e-02 | 1.160 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.348384e-02 | 1.272 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.348384e-02 | 1.272 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.383425e-02 | 1.195 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.168164e-02 | 1.287 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.732455e-02 | 1.242 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.317070e-02 | 1.199 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.447696e-02 | 1.264 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 6.383425e-02 | 1.195 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.447696e-02 | 1.264 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.616641e-02 | 1.179 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.129751e-02 | 1.290 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.650487e-02 | 1.248 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.627125e-02 | 1.179 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.348384e-02 | 1.272 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.168164e-02 | 1.287 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.229616e-02 | 1.141 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.730569e-02 | 1.242 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.229616e-02 | 1.141 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.387695e-02 | 1.131 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.133998e-02 | 1.290 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.347647e-02 | 1.134 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.423094e-02 | 1.192 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.229616e-02 | 1.141 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.904954e-02 | 1.229 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.696052e-02 | 1.174 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.022294e-02 | 1.220 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.920868e-02 | 1.160 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.920868e-02 | 1.160 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.261154e-02 | 1.203 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.629874e-02 | 1.250 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.977896e-02 | 1.156 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.407210e-02 | 1.130 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.407210e-02 | 1.130 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.407210e-02 | 1.130 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 7.407210e-02 | 1.130 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 7.407210e-02 | 1.130 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 7.407210e-02 | 1.130 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.407210e-02 | 1.130 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 7.407210e-02 | 1.130 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.407210e-02 | 1.130 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.542750e-02 | 1.122 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.542750e-02 | 1.122 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.542750e-02 | 1.122 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.860140e-02 | 1.105 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.860140e-02 | 1.105 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.860140e-02 | 1.105 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 8.419862e-02 | 1.075 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 8.419862e-02 | 1.075 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 9.421501e-02 | 1.026 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.041225e-01 | 0.982 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.041225e-01 | 0.982 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 1.041225e-01 | 0.982 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.041225e-01 | 0.982 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 1.041225e-01 | 0.982 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.139221e-01 | 0.943 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.139221e-01 | 0.943 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.236152e-01 | 0.908 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.236152e-01 | 0.908 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.236152e-01 | 0.908 | 1 | 1 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.332029e-01 | 0.875 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.426862e-01 | 0.846 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.426862e-01 | 0.846 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.426862e-01 | 0.846 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.426862e-01 | 0.846 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.520664e-01 | 0.818 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.520664e-01 | 0.818 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.613445e-01 | 0.792 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.613445e-01 | 0.792 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.613445e-01 | 0.792 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.613445e-01 | 0.792 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.613445e-01 | 0.792 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.613445e-01 | 0.792 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.506467e-02 | 1.022 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.195589e-01 | 0.922 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.416402e-01 | 0.849 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.454016e-01 | 0.837 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.506467e-02 | 1.022 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.506467e-02 | 1.022 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.332029e-01 | 0.875 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.169696e-02 | 1.038 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.135828e-01 | 0.945 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.613445e-01 | 0.792 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.613445e-01 | 0.792 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 1.147873e-01 | 0.940 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.139221e-01 | 0.943 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 1.321587e-01 | 0.879 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 9.421501e-02 | 1.026 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 1.332029e-01 | 0.875 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.520664e-01 | 0.818 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.846751e-02 | 1.007 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.231763e-01 | 0.909 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.124073e-01 | 0.949 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.426862e-01 | 0.846 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.520664e-01 | 0.818 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.520664e-01 | 0.818 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.520664e-01 | 0.818 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.520664e-01 | 0.818 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.506467e-02 | 1.022 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.195589e-01 | 0.922 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.147873e-01 | 0.940 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.416402e-01 | 0.849 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.171304e-01 | 0.931 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.033075e-01 | 0.986 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.613445e-01 | 0.792 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.181655e-02 | 1.087 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.041225e-01 | 0.982 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.332029e-01 | 0.875 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.529854e-01 | 0.815 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.419361e-01 | 0.848 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.147873e-01 | 0.940 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.506467e-02 | 1.022 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.506467e-02 | 1.022 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.957462e-02 | 1.002 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.419862e-02 | 1.075 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 1.041225e-01 | 0.982 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.520664e-01 | 0.818 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 1.613445e-01 | 0.792 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.019043e-01 | 0.992 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.019043e-01 | 0.992 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.231763e-01 | 0.909 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.416402e-01 | 0.849 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.454016e-01 | 0.837 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.366670e-02 | 1.028 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.454016e-01 | 0.837 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.421501e-02 | 1.026 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.613445e-01 | 0.792 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.613445e-01 | 0.792 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.613445e-01 | 0.792 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.507168e-02 | 1.070 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.169696e-02 | 1.038 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.181655e-02 | 1.087 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.437900e-01 | 0.842 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.041225e-01 | 0.982 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.041225e-01 | 0.982 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.236152e-01 | 0.908 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.332029e-01 | 0.875 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.613445e-01 | 0.792 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.181655e-02 | 1.087 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.181655e-02 | 1.087 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.507168e-02 | 1.070 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.507168e-02 | 1.070 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.416402e-01 | 0.849 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.491836e-01 | 0.826 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.236152e-01 | 0.908 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 1.426862e-01 | 0.846 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.613445e-01 | 0.792 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.613445e-01 | 0.792 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.613445e-01 | 0.792 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.019043e-01 | 0.992 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.019043e-01 | 0.992 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.341833e-01 | 0.872 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.416402e-01 | 0.849 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.124073e-01 | 0.949 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.202672e-01 | 0.920 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.218178e-01 | 0.914 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.568062e-01 | 0.805 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.124073e-01 | 0.949 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.124073e-01 | 0.949 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.289756e-01 | 0.889 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 1.139221e-01 | 0.943 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.506467e-02 | 1.022 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.846751e-02 | 1.007 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.846751e-02 | 1.007 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.053740e-01 | 0.977 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.454016e-01 | 0.837 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 1.606450e-01 | 0.794 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.302379e-01 | 0.885 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.529854e-01 | 0.815 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.518374e-01 | 0.819 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.189660e-01 | 0.925 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.236152e-01 | 0.908 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.169696e-02 | 1.038 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.088754e-01 | 0.963 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.124073e-01 | 0.949 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.159689e-01 | 0.936 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.591476e-02 | 1.066 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.568062e-01 | 0.805 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.159689e-01 | 0.936 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.846751e-02 | 1.007 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.159689e-01 | 0.936 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.147873e-01 | 0.940 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.218969e-01 | 0.914 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.379005e-01 | 0.860 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.416062e-01 | 0.849 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.156725e-01 | 0.937 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.547224e-01 | 0.810 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.159689e-01 | 0.936 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.159689e-01 | 0.936 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.379005e-01 | 0.860 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.153075e-01 | 0.938 | 1 | 1 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.454016e-01 | 0.837 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.445339e-02 | 1.025 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.169696e-02 | 1.038 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.379005e-01 | 0.860 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.957462e-02 | 1.002 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.416062e-01 | 0.849 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 1.019043e-01 | 0.992 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.181655e-02 | 1.087 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.159689e-01 | 0.936 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.340912e-01 | 0.873 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.267247e-01 | 0.897 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.304895e-01 | 0.884 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.304895e-01 | 0.884 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.218969e-01 | 0.914 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 1.341833e-01 | 0.872 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.379909e-01 | 0.860 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.445339e-02 | 1.025 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.645010e-01 | 0.784 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.705217e-01 | 0.768 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.705217e-01 | 0.768 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.705217e-01 | 0.768 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.705217e-01 | 0.768 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.705217e-01 | 0.768 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.705217e-01 | 0.768 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.722613e-01 | 0.764 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.722613e-01 | 0.764 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.722613e-01 | 0.764 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 1.722613e-01 | 0.764 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.722613e-01 | 0.764 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.795990e-01 | 0.746 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 1.795990e-01 | 0.746 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.795990e-01 | 0.746 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.800808e-01 | 0.745 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.800808e-01 | 0.745 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.840108e-01 | 0.735 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.849345e-01 | 0.733 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.852792e-01 | 0.732 | 1 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.865735e-01 | 0.729 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.885775e-01 | 0.725 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.885775e-01 | 0.725 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.885775e-01 | 0.725 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.885775e-01 | 0.725 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.885775e-01 | 0.725 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.885775e-01 | 0.725 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.885775e-01 | 0.725 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.885775e-01 | 0.725 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.902644e-01 | 0.721 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.920937e-01 | 0.716 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.946962e-01 | 0.711 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.962571e-01 | 0.707 | 1 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.974583e-01 | 0.705 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.974583e-01 | 0.705 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.974583e-01 | 0.705 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 1.974583e-01 | 0.705 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 1.974583e-01 | 0.705 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.974583e-01 | 0.705 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.974583e-01 | 0.705 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.974583e-01 | 0.705 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.974583e-01 | 0.705 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.974583e-01 | 0.705 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.974583e-01 | 0.705 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.974583e-01 | 0.705 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.038331e-01 | 0.691 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.062424e-01 | 0.686 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.062424e-01 | 0.686 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.062424e-01 | 0.686 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.062424e-01 | 0.686 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.062424e-01 | 0.686 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.062424e-01 | 0.686 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.118295e-01 | 0.674 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.118295e-01 | 0.674 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.118295e-01 | 0.674 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.118295e-01 | 0.674 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.118295e-01 | 0.674 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.119513e-01 | 0.674 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 2.149310e-01 | 0.668 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 2.149310e-01 | 0.668 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 2.149310e-01 | 0.668 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.149310e-01 | 0.668 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.149310e-01 | 0.668 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.149310e-01 | 0.668 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.158394e-01 | 0.666 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.158394e-01 | 0.666 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.158394e-01 | 0.666 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.158394e-01 | 0.666 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.158394e-01 | 0.666 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.174122e-01 | 0.663 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.198563e-01 | 0.658 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.202686e-01 | 0.657 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.219248e-01 | 0.654 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.231327e-01 | 0.651 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.231327e-01 | 0.651 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.235249e-01 | 0.651 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.235249e-01 | 0.651 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.235249e-01 | 0.651 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 2.235249e-01 | 0.651 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.235249e-01 | 0.651 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.235249e-01 | 0.651 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.238795e-01 | 0.650 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.279085e-01 | 0.642 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.319426e-01 | 0.635 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.320254e-01 | 0.634 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.320254e-01 | 0.634 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 2.320254e-01 | 0.634 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.320254e-01 | 0.634 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.320254e-01 | 0.634 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.359034e-01 | 0.627 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.359812e-01 | 0.627 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.359812e-01 | 0.627 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.375605e-01 | 0.624 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.377598e-01 | 0.624 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.377598e-01 | 0.624 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.404332e-01 | 0.619 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.404332e-01 | 0.619 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.404332e-01 | 0.619 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.404332e-01 | 0.619 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.433772e-01 | 0.614 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.440698e-01 | 0.612 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.440698e-01 | 0.612 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.440698e-01 | 0.612 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.487496e-01 | 0.604 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 2.487496e-01 | 0.604 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.487496e-01 | 0.604 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.487496e-01 | 0.604 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.487496e-01 | 0.604 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.487496e-01 | 0.604 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.487496e-01 | 0.604 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.487496e-01 | 0.604 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.521453e-01 | 0.598 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.521698e-01 | 0.598 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.521698e-01 | 0.598 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.524702e-01 | 0.598 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.569754e-01 | 0.590 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.569754e-01 | 0.590 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.569754e-01 | 0.590 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.569754e-01 | 0.590 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.643318e-01 | 0.578 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.651116e-01 | 0.577 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 2.651116e-01 | 0.577 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.651116e-01 | 0.577 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.651116e-01 | 0.577 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.651116e-01 | 0.577 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.651116e-01 | 0.577 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.651116e-01 | 0.577 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.724418e-01 | 0.565 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.727204e-01 | 0.564 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.727728e-01 | 0.564 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.731592e-01 | 0.564 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.731592e-01 | 0.564 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 2.731592e-01 | 0.564 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 2.731592e-01 | 0.564 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.764960e-01 | 0.558 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.764960e-01 | 0.558 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.764960e-01 | 0.558 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.787017e-01 | 0.555 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.805490e-01 | 0.552 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.811192e-01 | 0.551 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.811192e-01 | 0.551 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.811192e-01 | 0.551 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.816710e-01 | 0.550 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.877526e-01 | 0.541 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 2.889925e-01 | 0.539 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 2.889925e-01 | 0.539 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 2.889925e-01 | 0.539 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.889925e-01 | 0.539 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.889925e-01 | 0.539 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.889925e-01 | 0.539 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 2.889925e-01 | 0.539 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.889925e-01 | 0.539 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 2.889925e-01 | 0.539 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.889925e-01 | 0.539 | 1 | 1 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.911604e-01 | 0.536 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.926963e-01 | 0.534 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.935753e-01 | 0.532 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 2.936083e-01 | 0.532 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.967401e-01 | 0.528 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.967801e-01 | 0.528 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.967801e-01 | 0.528 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.967801e-01 | 0.528 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.967801e-01 | 0.528 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.967801e-01 | 0.528 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.007805e-01 | 0.522 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.044829e-01 | 0.516 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.044829e-01 | 0.516 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.044829e-01 | 0.516 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 3.044829e-01 | 0.516 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.044829e-01 | 0.516 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 3.044829e-01 | 0.516 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 3.044829e-01 | 0.516 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.048171e-01 | 0.516 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.058871e-01 | 0.514 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.114910e-01 | 0.507 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.121017e-01 | 0.506 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.121017e-01 | 0.506 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.121017e-01 | 0.506 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 3.128775e-01 | 0.505 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.128775e-01 | 0.505 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.128775e-01 | 0.505 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 3.196376e-01 | 0.495 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.196376e-01 | 0.495 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.196376e-01 | 0.495 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.196376e-01 | 0.495 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.249300e-01 | 0.488 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.270913e-01 | 0.485 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.270913e-01 | 0.485 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.270913e-01 | 0.485 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.289359e-01 | 0.483 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.329354e-01 | 0.478 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.344639e-01 | 0.476 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 3.344639e-01 | 0.476 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.344639e-01 | 0.476 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.417561e-01 | 0.466 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 3.417561e-01 | 0.466 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.417561e-01 | 0.466 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.417561e-01 | 0.466 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.417561e-01 | 0.466 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.429984e-01 | 0.465 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.448924e-01 | 0.462 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.448924e-01 | 0.462 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.448924e-01 | 0.462 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.460582e-01 | 0.461 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 3.473831e-01 | 0.459 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.488631e-01 | 0.457 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.489689e-01 | 0.457 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.489689e-01 | 0.457 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.489689e-01 | 0.457 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.489689e-01 | 0.457 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.489689e-01 | 0.457 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.503703e-01 | 0.455 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.528258e-01 | 0.452 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.528258e-01 | 0.452 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.533561e-01 | 0.452 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.561031e-01 | 0.448 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.561031e-01 | 0.448 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.561031e-01 | 0.448 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.561031e-01 | 0.448 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.561031e-01 | 0.448 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.593229e-01 | 0.445 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.607261e-01 | 0.443 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.631595e-01 | 0.440 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 3.631595e-01 | 0.440 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 3.631595e-01 | 0.440 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.631595e-01 | 0.440 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.631595e-01 | 0.440 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.653495e-01 | 0.437 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.701391e-01 | 0.432 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 3.701391e-01 | 0.432 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.764180e-01 | 0.424 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.770425e-01 | 0.424 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.770425e-01 | 0.424 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.770425e-01 | 0.424 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.770425e-01 | 0.424 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.803168e-01 | 0.420 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.803168e-01 | 0.420 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.838708e-01 | 0.416 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.838708e-01 | 0.416 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.838708e-01 | 0.416 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.838708e-01 | 0.416 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.842054e-01 | 0.415 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.842054e-01 | 0.415 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.880836e-01 | 0.411 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.880836e-01 | 0.411 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.973048e-01 | 0.401 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.973048e-01 | 0.401 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.973048e-01 | 0.401 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.973048e-01 | 0.401 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.996532e-01 | 0.398 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.039121e-01 | 0.394 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.039121e-01 | 0.394 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.039121e-01 | 0.394 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.039121e-01 | 0.394 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 4.039121e-01 | 0.394 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.059513e-01 | 0.392 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.169116e-01 | 0.380 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.169116e-01 | 0.380 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.169116e-01 | 0.380 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.169116e-01 | 0.380 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 4.217447e-01 | 0.375 | 1 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.233052e-01 | 0.373 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.233052e-01 | 0.373 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.233052e-01 | 0.373 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.296291e-01 | 0.367 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.328953e-01 | 0.364 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.337284e-01 | 0.363 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 4.358840e-01 | 0.361 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.358840e-01 | 0.361 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.358840e-01 | 0.361 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.358840e-01 | 0.361 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.374517e-01 | 0.359 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.374517e-01 | 0.359 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.386646e-01 | 0.358 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.420707e-01 | 0.355 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.420707e-01 | 0.355 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.448585e-01 | 0.352 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.481900e-01 | 0.349 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.481900e-01 | 0.349 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.555354e-01 | 0.341 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.576643e-01 | 0.339 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.595088e-01 | 0.338 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.631366e-01 | 0.334 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.631366e-01 | 0.334 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.672492e-01 | 0.330 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.720068e-01 | 0.326 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.777995e-01 | 0.321 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.777995e-01 | 0.321 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.835290e-01 | 0.316 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.835290e-01 | 0.316 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.835290e-01 | 0.316 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.835290e-01 | 0.316 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.881266e-01 | 0.311 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.891960e-01 | 0.311 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.948012e-01 | 0.306 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.948012e-01 | 0.306 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.003452e-01 | 0.301 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.003452e-01 | 0.301 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.020794e-01 | 0.299 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.058287e-01 | 0.296 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.058287e-01 | 0.296 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.058287e-01 | 0.296 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.058287e-01 | 0.296 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.058287e-01 | 0.296 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.058287e-01 | 0.296 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.089642e-01 | 0.293 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.112524e-01 | 0.291 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.112524e-01 | 0.291 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.166168e-01 | 0.287 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.219228e-01 | 0.282 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.219228e-01 | 0.282 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.219228e-01 | 0.282 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.219228e-01 | 0.282 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.219228e-01 | 0.282 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.219228e-01 | 0.282 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.221003e-01 | 0.282 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.259037e-01 | 0.279 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.259037e-01 | 0.279 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.271708e-01 | 0.278 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 5.271708e-01 | 0.278 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 5.271708e-01 | 0.278 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.271708e-01 | 0.278 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.323615e-01 | 0.274 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.323615e-01 | 0.274 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.323615e-01 | 0.274 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.323615e-01 | 0.274 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.325691e-01 | 0.274 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.374955e-01 | 0.270 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.374955e-01 | 0.270 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.374955e-01 | 0.270 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.425735e-01 | 0.266 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.425735e-01 | 0.266 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.425735e-01 | 0.266 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.425735e-01 | 0.266 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.457084e-01 | 0.263 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.457084e-01 | 0.263 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.475961e-01 | 0.262 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.521293e-01 | 0.258 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.574773e-01 | 0.254 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.574773e-01 | 0.254 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 5.574773e-01 | 0.254 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 5.585897e-01 | 0.253 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.617695e-01 | 0.250 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.617695e-01 | 0.250 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 5.623371e-01 | 0.250 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.623371e-01 | 0.250 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.623371e-01 | 0.250 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 5.671439e-01 | 0.246 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.671439e-01 | 0.246 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.680801e-01 | 0.246 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.743254e-01 | 0.241 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 5.766004e-01 | 0.239 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.766004e-01 | 0.239 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.797436e-01 | 0.237 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.812514e-01 | 0.236 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.812514e-01 | 0.236 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.838421e-01 | 0.234 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.858516e-01 | 0.232 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.858516e-01 | 0.232 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.904015e-01 | 0.229 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.904015e-01 | 0.229 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.904015e-01 | 0.229 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.946749e-01 | 0.226 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.993527e-01 | 0.222 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.993527e-01 | 0.222 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.993527e-01 | 0.222 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.037551e-01 | 0.219 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 6.056506e-01 | 0.218 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.060396e-01 | 0.217 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.124161e-01 | 0.213 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.124161e-01 | 0.213 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.124161e-01 | 0.213 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.162038e-01 | 0.210 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.166757e-01 | 0.210 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.166757e-01 | 0.210 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.208888e-01 | 0.207 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 6.247589e-01 | 0.204 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 6.247589e-01 | 0.204 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 6.250559e-01 | 0.204 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.250559e-01 | 0.204 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 6.250559e-01 | 0.204 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.291774e-01 | 0.201 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.332538e-01 | 0.198 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.372857e-01 | 0.196 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.412735e-01 | 0.193 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.414276e-01 | 0.193 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.469654e-01 | 0.189 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 6.500591e-01 | 0.187 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.529773e-01 | 0.185 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.567935e-01 | 0.183 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.567935e-01 | 0.183 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.643013e-01 | 0.178 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.679125e-01 | 0.175 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.679937e-01 | 0.175 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.730172e-01 | 0.172 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.752577e-01 | 0.171 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.752577e-01 | 0.171 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.780585e-01 | 0.169 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.858586e-01 | 0.164 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.858586e-01 | 0.164 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.893151e-01 | 0.162 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.893151e-01 | 0.162 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.927339e-01 | 0.159 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.994596e-01 | 0.155 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.994596e-01 | 0.155 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.994596e-01 | 0.155 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.994596e-01 | 0.155 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 7.027673e-01 | 0.153 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.027673e-01 | 0.153 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.060389e-01 | 0.151 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.092746e-01 | 0.149 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.124749e-01 | 0.147 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.156402e-01 | 0.145 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.187708e-01 | 0.143 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.218672e-01 | 0.142 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.218672e-01 | 0.142 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.218672e-01 | 0.142 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.249297e-01 | 0.140 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.309543e-01 | 0.136 | 0 | 0 |
| Translation | R-HSA-72766 | 7.313046e-01 | 0.136 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.339173e-01 | 0.134 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.339173e-01 | 0.134 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.339173e-01 | 0.134 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.368478e-01 | 0.133 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 7.397462e-01 | 0.131 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 7.426129e-01 | 0.129 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.442634e-01 | 0.128 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.454481e-01 | 0.128 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.478705e-01 | 0.126 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.482523e-01 | 0.126 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.537689e-01 | 0.123 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 7.540606e-01 | 0.123 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.564820e-01 | 0.121 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.591653e-01 | 0.120 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.591653e-01 | 0.120 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.591653e-01 | 0.120 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.618192e-01 | 0.118 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.618192e-01 | 0.118 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.644441e-01 | 0.117 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.644441e-01 | 0.117 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.696078e-01 | 0.114 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.696078e-01 | 0.114 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.771430e-01 | 0.109 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.771430e-01 | 0.109 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 7.777828e-01 | 0.109 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.820299e-01 | 0.107 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.868101e-01 | 0.104 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.868101e-01 | 0.104 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.868101e-01 | 0.104 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.934147e-01 | 0.100 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 8.027348e-01 | 0.095 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.027348e-01 | 0.095 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 8.174761e-01 | 0.088 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.174761e-01 | 0.088 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.232259e-01 | 0.084 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 8.311216e-01 | 0.080 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.384585e-01 | 0.077 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.505433e-01 | 0.070 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.505433e-01 | 0.070 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 8.517765e-01 | 0.070 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.521947e-01 | 0.069 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.554433e-01 | 0.068 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.554433e-01 | 0.068 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.570408e-01 | 0.067 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.627104e-01 | 0.064 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.662640e-01 | 0.062 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.675212e-01 | 0.062 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.762790e-01 | 0.057 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.868145e-01 | 0.052 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.897376e-01 | 0.051 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 8.935768e-01 | 0.049 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.941262e-01 | 0.049 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.971365e-01 | 0.047 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.987377e-01 | 0.046 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.999996e-01 | 0.046 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.009680e-01 | 0.045 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.042222e-01 | 0.044 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.073700e-01 | 0.042 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.123894e-01 | 0.040 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.180569e-01 | 0.037 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.349098e-01 | 0.029 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.386905e-01 | 0.027 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.456217e-01 | 0.024 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.498598e-01 | 0.022 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.504413e-01 | 0.022 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.588909e-01 | 0.018 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.684442e-01 | 0.014 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.730592e-01 | 0.012 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.819240e-01 | 0.008 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.860457e-01 | 0.006 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.897067e-01 | 0.004 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.901608e-01 | 0.004 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.937077e-01 | 0.003 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.980942e-01 | 0.001 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.989248e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999286e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.110223e-16 | 15.955 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.776357e-15 | 14.750 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.195844e-14 | 13.284 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.524336e-13 | 12.817 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.753353e-13 | 12.560 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.043277e-12 | 11.982 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.494827e-12 | 11.260 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.296963e-12 | 11.201 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.245715e-11 | 10.905 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.534572e-11 | 10.814 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.792544e-11 | 10.747 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.736034e-11 | 10.760 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.767919e-11 | 10.558 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.026512e-11 | 10.395 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.245046e-10 | 9.905 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.459503e-10 | 9.836 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.064275e-10 | 9.685 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.876098e-10 | 9.412 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.750256e-10 | 9.111 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.085690e-09 | 8.964 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.353911e-09 | 8.868 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.624694e-09 | 8.789 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.017997e-09 | 8.695 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.709031e-09 | 8.567 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.654255e-09 | 8.576 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.955698e-09 | 8.529 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.560160e-09 | 8.449 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.793368e-09 | 8.421 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.786729e-09 | 8.168 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.709737e-09 | 8.113 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.751833e-09 | 8.058 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.406263e-09 | 8.027 | 1 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.720255e-09 | 8.012 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.223029e-08 | 7.913 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.456077e-08 | 7.837 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.792430e-08 | 7.747 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.445868e-08 | 7.612 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.577337e-08 | 7.589 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.415048e-08 | 7.467 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.071565e-08 | 7.390 | 1 | 1 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.510555e-08 | 7.346 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.926787e-08 | 7.307 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.622925e-08 | 7.250 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.144506e-08 | 7.089 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.769290e-08 | 7.057 | 1 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.011602e-07 | 6.995 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.659051e-07 | 6.780 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.675134e-07 | 6.776 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.262781e-07 | 6.645 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.710755e-07 | 6.567 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.020603e-07 | 6.520 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.730816e-07 | 6.428 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.431637e-07 | 6.353 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 4.228873e-07 | 6.374 | 1 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.804265e-07 | 6.318 | 1 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.195290e-07 | 6.284 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.195472e-07 | 6.284 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.235329e-07 | 6.141 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.067412e-07 | 6.093 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.172286e-07 | 6.088 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.109506e-06 | 5.955 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.109388e-06 | 5.955 | 1 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.199518e-06 | 5.921 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.250965e-06 | 5.903 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.266152e-06 | 5.898 | 1 | 0 |
| M Phase | R-HSA-68886 | 1.588610e-06 | 5.799 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.661454e-06 | 5.780 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.814044e-06 | 5.741 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.053403e-06 | 5.688 | 1 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.402080e-06 | 5.619 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.427491e-06 | 5.615 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.814696e-06 | 5.551 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.269330e-06 | 5.486 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.041317e-06 | 5.517 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.425320e-06 | 5.465 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.575652e-06 | 5.340 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.648328e-06 | 5.333 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.803602e-06 | 5.318 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.649214e-06 | 5.116 | 1 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.442253e-06 | 5.074 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.474155e-06 | 5.023 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.877535e-06 | 5.005 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.082431e-05 | 4.966 | 1 | 0 |
| Hemostasis | R-HSA-109582 | 1.500314e-05 | 4.824 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.605021e-05 | 4.795 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.734265e-05 | 4.761 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.753452e-05 | 4.756 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.799674e-05 | 4.745 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.143523e-05 | 4.669 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.774727e-05 | 4.557 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.723800e-05 | 4.565 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.792272e-05 | 4.554 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.933790e-05 | 4.533 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.043298e-05 | 4.517 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.332722e-05 | 4.477 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.338314e-05 | 4.476 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.598487e-05 | 4.444 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.208812e-05 | 4.376 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.367216e-05 | 4.360 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.367216e-05 | 4.360 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.567737e-05 | 4.254 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.567085e-05 | 4.121 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.247245e-05 | 4.084 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.211850e-05 | 4.036 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.101347e-04 | 3.958 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.157016e-04 | 3.937 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.215779e-04 | 3.915 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.215779e-04 | 3.915 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.277612e-04 | 3.894 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.309675e-04 | 3.883 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.401003e-04 | 3.854 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.411679e-04 | 3.850 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.518578e-04 | 3.819 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.745051e-04 | 3.758 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.841048e-04 | 3.735 | 1 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.354454e-04 | 3.628 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.458722e-04 | 3.609 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.476026e-04 | 3.606 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.477035e-04 | 3.606 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.517305e-04 | 3.599 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.623827e-04 | 3.581 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.716377e-04 | 3.566 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.797524e-04 | 3.553 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.957016e-04 | 3.529 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.957016e-04 | 3.529 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.957016e-04 | 3.529 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.033168e-04 | 3.518 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.033168e-04 | 3.518 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.201068e-04 | 3.495 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 3.826704e-04 | 3.417 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.964909e-04 | 3.402 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.964909e-04 | 3.402 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.518253e-04 | 3.345 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.801085e-04 | 3.319 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.624680e-04 | 3.250 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.764550e-04 | 3.239 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.244429e-04 | 3.205 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.751133e-04 | 3.171 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.297100e-04 | 3.081 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.297100e-04 | 3.081 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.018629e-04 | 3.154 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.297100e-04 | 3.081 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.620838e-04 | 3.064 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.620838e-04 | 3.064 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.620838e-04 | 3.064 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.620838e-04 | 3.064 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.620838e-04 | 3.064 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.620838e-04 | 3.064 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.620838e-04 | 3.064 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.620838e-04 | 3.064 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.620838e-04 | 3.064 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.620838e-04 | 3.064 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.620838e-04 | 3.064 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.972382e-04 | 3.047 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.972382e-04 | 3.047 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.773437e-04 | 3.010 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.082339e-03 | 2.966 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.082339e-03 | 2.966 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.140624e-03 | 2.943 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.149907e-03 | 2.939 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.200572e-03 | 2.921 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.337704e-03 | 2.874 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.357737e-03 | 2.867 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.371049e-03 | 2.863 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.730276e-03 | 2.762 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.928031e-03 | 2.715 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.743732e-03 | 2.759 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.906717e-03 | 2.720 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.961957e-03 | 2.707 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.070407e-03 | 2.684 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.193217e-03 | 2.659 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.217304e-03 | 2.654 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.386527e-03 | 2.622 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.481122e-03 | 2.605 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.481122e-03 | 2.605 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.554661e-03 | 2.593 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.664916e-03 | 2.574 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.730755e-03 | 2.564 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.730755e-03 | 2.564 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.730755e-03 | 2.564 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.730755e-03 | 2.564 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.889862e-03 | 2.539 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.308630e-03 | 2.480 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 3.406417e-03 | 2.468 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.518386e-03 | 2.454 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.685345e-03 | 2.434 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.964656e-03 | 2.402 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.215923e-03 | 2.375 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.227609e-03 | 2.374 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.517723e-03 | 2.345 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.802986e-03 | 2.318 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.969045e-03 | 2.304 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.145531e-03 | 2.289 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.169051e-03 | 2.287 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.244422e-03 | 2.280 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.315463e-03 | 2.274 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.366922e-03 | 2.270 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.825018e-03 | 2.235 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.336806e-03 | 2.134 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.821837e-03 | 2.107 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.775017e-03 | 2.169 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.851151e-03 | 2.105 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.504835e-03 | 2.125 | 1 | 1 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.341542e-03 | 2.134 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.420760e-03 | 2.130 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.322590e-03 | 2.080 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.887448e-03 | 2.103 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.795978e-03 | 2.108 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.378286e-03 | 2.077 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.461846e-03 | 2.073 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.461846e-03 | 2.073 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 8.557015e-03 | 2.068 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.557015e-03 | 2.068 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.709935e-03 | 2.060 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.969783e-03 | 2.047 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.010076e-03 | 2.045 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.010076e-03 | 2.045 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.290575e-03 | 2.032 | 1 | 1 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.375541e-03 | 2.028 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 9.856097e-03 | 2.006 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.953248e-03 | 2.002 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.050183e-02 | 1.979 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.050183e-02 | 1.979 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.050183e-02 | 1.979 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.050183e-02 | 1.979 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.050183e-02 | 1.979 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.050183e-02 | 1.979 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.066396e-02 | 1.972 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.066396e-02 | 1.972 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.089581e-02 | 1.963 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.100110e-02 | 1.959 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.100110e-02 | 1.959 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 1.123692e-02 | 1.949 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.123692e-02 | 1.949 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.131343e-02 | 1.946 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.147541e-02 | 1.940 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.169723e-02 | 1.932 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.241315e-02 | 1.906 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.269399e-02 | 1.896 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.269764e-02 | 1.896 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.269764e-02 | 1.896 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.316413e-02 | 1.881 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.316413e-02 | 1.881 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.393515e-02 | 1.856 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.393515e-02 | 1.856 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.410062e-02 | 1.851 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.555287e-02 | 1.808 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.555287e-02 | 1.808 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 1.585158e-02 | 1.800 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.585158e-02 | 1.800 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.585158e-02 | 1.800 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.585158e-02 | 1.800 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.657760e-02 | 1.780 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.754127e-02 | 1.756 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 1.754127e-02 | 1.756 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.754127e-02 | 1.756 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.754127e-02 | 1.756 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.754813e-02 | 1.756 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.816986e-02 | 1.741 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.909322e-02 | 1.719 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.930378e-02 | 1.714 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.930378e-02 | 1.714 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 2.304054e-02 | 1.638 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.501148e-02 | 1.602 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.915038e-02 | 1.535 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.501148e-02 | 1.602 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.704862e-02 | 1.568 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.363162e-02 | 1.627 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.437703e-02 | 1.613 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.914747e-02 | 1.535 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.915038e-02 | 1.535 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.750027e-02 | 1.561 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.304054e-02 | 1.638 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.113743e-02 | 1.675 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.004216e-02 | 1.698 | 0 | 0 |
| Signaling by FGFR3 fusions in cancer | R-HSA-8853334 | 3.117770e-02 | 1.506 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.117770e-02 | 1.506 | 0 | 0 |
| t(4;14) translocations of FGFR3 | R-HSA-2033515 | 3.117770e-02 | 1.506 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.117770e-02 | 1.506 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.117770e-02 | 1.506 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.117770e-02 | 1.506 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.117770e-02 | 1.506 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.117770e-02 | 1.506 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.117770e-02 | 1.506 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.131519e-02 | 1.504 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.131519e-02 | 1.504 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.172607e-02 | 1.499 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.299006e-02 | 1.482 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 3.354151e-02 | 1.474 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.354151e-02 | 1.474 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.354151e-02 | 1.474 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.354151e-02 | 1.474 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.582782e-02 | 1.446 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.582782e-02 | 1.446 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.582782e-02 | 1.446 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.601155e-02 | 1.444 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.817264e-02 | 1.418 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.869799e-02 | 1.412 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.923980e-02 | 1.406 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.007852e-02 | 1.397 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.007852e-02 | 1.397 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.057451e-02 | 1.392 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.057451e-02 | 1.392 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.135400e-02 | 1.383 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.135400e-02 | 1.383 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.297267e-02 | 1.367 | 1 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.303197e-02 | 1.366 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.303197e-02 | 1.366 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.303197e-02 | 1.366 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.303197e-02 | 1.366 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.303197e-02 | 1.366 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.319006e-02 | 1.365 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.042758e-02 | 1.297 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.072391e-02 | 1.295 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.072391e-02 | 1.295 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 5.142402e-02 | 1.289 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.142402e-02 | 1.289 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.210723e-02 | 1.283 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.338983e-02 | 1.273 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.338983e-02 | 1.273 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.360068e-02 | 1.271 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.583821e-02 | 1.253 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.597492e-02 | 1.252 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.610450e-02 | 1.251 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.610450e-02 | 1.251 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.610450e-02 | 1.251 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.630093e-02 | 1.249 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.138889e-02 | 1.212 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.138889e-02 | 1.212 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.124968e-02 | 1.147 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.124968e-02 | 1.147 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 7.124968e-02 | 1.147 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 7.124968e-02 | 1.147 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.100748e-02 | 1.091 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 9.066336e-02 | 1.043 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 1.002184e-01 | 0.999 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.096736e-01 | 0.960 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.096736e-01 | 0.960 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.742483e-02 | 1.171 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.334456e-02 | 1.135 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.096736e-01 | 0.960 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.085285e-01 | 0.964 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 7.124968e-02 | 1.147 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.002184e-01 | 0.999 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.096736e-01 | 0.960 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.096736e-01 | 0.960 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.036407e-02 | 1.153 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.853571e-02 | 1.006 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 1.051679e-01 | 0.978 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.100748e-02 | 1.091 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.096736e-01 | 0.960 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.334456e-02 | 1.135 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.085285e-01 | 0.964 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 6.138889e-02 | 1.212 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 8.100748e-02 | 1.091 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.886660e-02 | 1.230 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.119174e-01 | 0.951 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 6.338680e-02 | 1.198 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.036407e-02 | 1.153 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.252175e-02 | 1.083 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 1.002184e-01 | 0.999 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.167486e-02 | 1.210 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.334456e-02 | 1.135 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.334456e-02 | 1.135 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.526610e-02 | 1.021 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.526610e-02 | 1.021 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.119174e-01 | 0.951 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.153337e-01 | 0.938 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.452802e-02 | 1.190 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.942455e-02 | 1.100 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.565560e-02 | 1.067 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.022719e-02 | 1.220 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.452802e-02 | 1.190 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.138889e-02 | 1.212 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.124968e-02 | 1.147 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 7.124968e-02 | 1.147 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.636510e-02 | 1.117 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 7.942455e-02 | 1.100 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.942455e-02 | 1.100 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.007061e-01 | 0.997 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.100748e-02 | 1.091 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.100748e-02 | 1.091 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.002184e-01 | 0.999 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.742483e-02 | 1.171 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.036407e-02 | 1.153 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.036407e-02 | 1.153 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.334456e-02 | 1.135 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.526610e-02 | 1.021 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.526610e-02 | 1.021 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.437882e-02 | 1.025 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.000082e-02 | 1.097 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.144452e-02 | 1.146 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.085285e-01 | 0.964 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.202885e-02 | 1.036 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.202885e-02 | 1.036 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.367787e-02 | 1.196 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.721824e-02 | 1.173 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.452802e-02 | 1.190 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.565560e-02 | 1.067 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.018366e-01 | 0.992 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.051679e-01 | 0.978 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.085285e-01 | 0.964 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.252175e-02 | 1.083 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.853571e-02 | 1.006 | 1 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.693803e-02 | 1.014 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.085285e-01 | 0.964 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.882500e-02 | 1.051 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.202885e-02 | 1.036 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.085285e-01 | 0.964 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.096736e-01 | 0.960 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.068302e-01 | 0.971 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.085285e-01 | 0.964 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.085285e-01 | 0.964 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.886660e-02 | 1.230 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.822331e-02 | 1.054 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.565560e-02 | 1.067 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 7.133813e-02 | 1.147 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.051505e-01 | 0.978 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.005829e-02 | 1.097 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.190300e-01 | 0.924 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.190300e-01 | 0.924 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.190300e-01 | 0.924 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.190300e-01 | 0.924 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.190300e-01 | 0.924 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.190300e-01 | 0.924 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.190300e-01 | 0.924 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.190300e-01 | 0.924 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.222448e-01 | 0.913 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.222448e-01 | 0.913 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.252745e-01 | 0.902 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.257378e-01 | 0.901 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.257378e-01 | 0.901 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.282887e-01 | 0.892 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.282887e-01 | 0.892 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.282887e-01 | 0.892 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.282887e-01 | 0.892 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.282887e-01 | 0.892 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.282887e-01 | 0.892 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.282887e-01 | 0.892 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.282887e-01 | 0.892 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.292544e-01 | 0.889 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.292544e-01 | 0.889 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.292544e-01 | 0.889 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.327940e-01 | 0.877 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.327940e-01 | 0.877 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.327940e-01 | 0.877 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.346992e-01 | 0.871 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.363555e-01 | 0.865 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.363555e-01 | 0.865 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.363555e-01 | 0.865 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.363555e-01 | 0.865 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.374506e-01 | 0.862 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.374506e-01 | 0.862 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.374506e-01 | 0.862 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.374506e-01 | 0.862 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.374506e-01 | 0.862 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.374506e-01 | 0.862 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.399382e-01 | 0.854 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.399382e-01 | 0.854 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.422737e-01 | 0.847 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.435412e-01 | 0.843 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.443613e-01 | 0.841 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.465168e-01 | 0.834 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.465168e-01 | 0.834 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.465168e-01 | 0.834 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.465168e-01 | 0.834 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 1.465168e-01 | 0.834 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.466998e-01 | 0.834 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.466998e-01 | 0.834 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.471637e-01 | 0.832 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.471637e-01 | 0.832 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.471637e-01 | 0.832 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.471637e-01 | 0.832 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.471637e-01 | 0.832 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.544640e-01 | 0.811 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.554882e-01 | 0.808 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.554882e-01 | 0.808 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.554882e-01 | 0.808 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.554882e-01 | 0.808 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.554882e-01 | 0.808 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.554882e-01 | 0.808 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.554882e-01 | 0.808 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.554882e-01 | 0.808 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.554882e-01 | 0.808 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.618330e-01 | 0.791 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 1.618330e-01 | 0.791 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.643659e-01 | 0.784 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.643659e-01 | 0.784 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.643659e-01 | 0.784 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.643659e-01 | 0.784 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.643659e-01 | 0.784 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.643659e-01 | 0.784 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.643659e-01 | 0.784 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.643659e-01 | 0.784 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.643659e-01 | 0.784 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.643659e-01 | 0.784 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.655413e-01 | 0.781 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.655413e-01 | 0.781 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.692646e-01 | 0.771 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.730020e-01 | 0.762 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.731508e-01 | 0.762 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.731508e-01 | 0.762 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.731508e-01 | 0.762 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 1.731508e-01 | 0.762 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.731508e-01 | 0.762 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.731508e-01 | 0.762 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.731508e-01 | 0.762 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.805168e-01 | 0.743 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.818439e-01 | 0.740 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.818439e-01 | 0.740 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.818439e-01 | 0.740 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.818439e-01 | 0.740 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.818439e-01 | 0.740 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.818439e-01 | 0.740 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.818439e-01 | 0.740 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.880800e-01 | 0.726 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.892894e-01 | 0.723 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.903671e-01 | 0.720 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 1.904462e-01 | 0.720 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.904462e-01 | 0.720 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.904462e-01 | 0.720 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.904462e-01 | 0.720 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.918782e-01 | 0.717 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.989585e-01 | 0.701 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.989585e-01 | 0.701 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.989585e-01 | 0.701 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.989585e-01 | 0.701 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.989585e-01 | 0.701 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.989585e-01 | 0.701 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.989585e-01 | 0.701 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.995045e-01 | 0.700 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.995045e-01 | 0.700 | 0 | 0 |
| Translation | R-HSA-72766 | 1.998731e-01 | 0.699 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.033314e-01 | 0.692 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.033314e-01 | 0.692 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 2.033314e-01 | 0.692 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.033314e-01 | 0.692 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.064623e-01 | 0.685 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.071666e-01 | 0.684 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.073818e-01 | 0.683 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.073818e-01 | 0.683 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.073818e-01 | 0.683 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.110095e-01 | 0.676 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.110095e-01 | 0.676 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.130193e-01 | 0.672 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.157171e-01 | 0.666 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.157171e-01 | 0.666 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.157171e-01 | 0.666 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.157171e-01 | 0.666 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.198430e-01 | 0.658 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.201040e-01 | 0.657 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.239652e-01 | 0.650 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.239652e-01 | 0.650 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.239652e-01 | 0.650 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.239652e-01 | 0.650 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 2.239652e-01 | 0.650 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 2.239652e-01 | 0.650 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.239652e-01 | 0.650 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.256122e-01 | 0.647 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.303202e-01 | 0.638 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.303202e-01 | 0.638 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.321271e-01 | 0.634 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.321271e-01 | 0.634 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.402037e-01 | 0.619 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.402037e-01 | 0.619 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.402037e-01 | 0.619 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.402037e-01 | 0.619 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.424647e-01 | 0.615 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.466897e-01 | 0.608 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.481957e-01 | 0.605 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.481957e-01 | 0.605 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.481957e-01 | 0.605 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.481957e-01 | 0.605 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.497418e-01 | 0.603 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.536338e-01 | 0.596 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.561043e-01 | 0.592 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.561043e-01 | 0.592 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.561043e-01 | 0.592 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.561043e-01 | 0.592 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.575273e-01 | 0.589 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.575273e-01 | 0.589 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.614219e-01 | 0.583 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.639301e-01 | 0.579 | 1 | 1 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.639301e-01 | 0.579 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.653170e-01 | 0.576 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.676640e-01 | 0.572 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.676640e-01 | 0.572 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.716740e-01 | 0.566 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.716740e-01 | 0.566 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.716740e-01 | 0.566 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.731071e-01 | 0.564 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.733475e-01 | 0.563 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.770013e-01 | 0.558 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.793370e-01 | 0.554 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.793370e-01 | 0.554 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.869198e-01 | 0.542 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.869198e-01 | 0.542 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.869198e-01 | 0.542 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.869198e-01 | 0.542 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.886754e-01 | 0.540 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.944233e-01 | 0.531 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.944233e-01 | 0.531 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.944233e-01 | 0.531 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.944233e-01 | 0.531 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.944233e-01 | 0.531 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.951824e-01 | 0.530 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 2.964472e-01 | 0.528 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.964472e-01 | 0.528 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.018483e-01 | 0.520 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.018483e-01 | 0.520 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.018483e-01 | 0.520 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.018483e-01 | 0.520 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.018483e-01 | 0.520 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.080810e-01 | 0.511 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.080810e-01 | 0.511 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.091956e-01 | 0.510 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.091956e-01 | 0.510 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.091956e-01 | 0.510 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.091956e-01 | 0.510 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.091956e-01 | 0.510 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.158167e-01 | 0.501 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.164660e-01 | 0.500 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.164660e-01 | 0.500 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.164660e-01 | 0.500 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.164660e-01 | 0.500 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.164660e-01 | 0.500 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 3.195203e-01 | 0.496 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.196775e-01 | 0.495 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.220354e-01 | 0.492 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.235333e-01 | 0.490 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.236604e-01 | 0.490 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.236604e-01 | 0.490 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.236604e-01 | 0.490 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.273835e-01 | 0.485 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.307794e-01 | 0.480 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.307794e-01 | 0.480 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.312280e-01 | 0.480 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.332777e-01 | 0.477 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.350665e-01 | 0.475 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.378240e-01 | 0.471 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.378240e-01 | 0.471 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.378240e-01 | 0.471 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.380435e-01 | 0.471 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 3.385376e-01 | 0.470 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.427240e-01 | 0.465 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.427240e-01 | 0.465 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.447949e-01 | 0.462 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.478953e-01 | 0.459 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.516928e-01 | 0.454 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.516928e-01 | 0.454 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.516928e-01 | 0.454 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.516928e-01 | 0.454 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.579538e-01 | 0.446 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.585185e-01 | 0.445 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.593654e-01 | 0.444 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.617419e-01 | 0.442 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.617419e-01 | 0.442 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.619008e-01 | 0.441 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.652727e-01 | 0.437 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.652727e-01 | 0.437 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.652727e-01 | 0.437 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.655218e-01 | 0.437 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.719563e-01 | 0.430 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.719563e-01 | 0.430 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.719563e-01 | 0.430 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.736633e-01 | 0.428 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.785699e-01 | 0.422 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.785699e-01 | 0.422 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.851142e-01 | 0.414 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.851142e-01 | 0.414 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.851142e-01 | 0.414 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.880148e-01 | 0.411 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.881191e-01 | 0.411 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.915900e-01 | 0.407 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.915900e-01 | 0.407 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.915900e-01 | 0.407 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.915900e-01 | 0.407 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.915900e-01 | 0.407 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.917305e-01 | 0.407 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.954361e-01 | 0.403 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.954361e-01 | 0.403 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.979981e-01 | 0.400 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.991316e-01 | 0.399 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.991316e-01 | 0.399 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.077024e-01 | 0.390 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.101545e-01 | 0.387 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.106135e-01 | 0.387 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.138071e-01 | 0.383 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.161327e-01 | 0.381 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 4.161327e-01 | 0.381 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.168223e-01 | 0.380 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.168223e-01 | 0.380 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.229661e-01 | 0.374 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.229661e-01 | 0.374 | 0 | 0 |
| Methylation | R-HSA-156581 | 4.229661e-01 | 0.374 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.283044e-01 | 0.368 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.290456e-01 | 0.367 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.290456e-01 | 0.367 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.350613e-01 | 0.361 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.350613e-01 | 0.361 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.350613e-01 | 0.361 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.350613e-01 | 0.361 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.354828e-01 | 0.361 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.466969e-01 | 0.350 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.469045e-01 | 0.350 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.469045e-01 | 0.350 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.469045e-01 | 0.350 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.469045e-01 | 0.350 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.642080e-01 | 0.333 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.698553e-01 | 0.328 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.698553e-01 | 0.328 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.698553e-01 | 0.328 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.754435e-01 | 0.323 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.754435e-01 | 0.323 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.754435e-01 | 0.323 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.809732e-01 | 0.318 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.819791e-01 | 0.317 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.910832e-01 | 0.309 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.910832e-01 | 0.309 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.918592e-01 | 0.308 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.918592e-01 | 0.308 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.918592e-01 | 0.308 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.972168e-01 | 0.303 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.972168e-01 | 0.303 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.972168e-01 | 0.303 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.979079e-01 | 0.303 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.044433e-01 | 0.297 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.110385e-01 | 0.292 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 5.208236e-01 | 0.283 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.231740e-01 | 0.281 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.240563e-01 | 0.281 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.240563e-01 | 0.281 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.304781e-01 | 0.275 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.304781e-01 | 0.275 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.331798e-01 | 0.273 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.331798e-01 | 0.273 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.331798e-01 | 0.273 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.366223e-01 | 0.270 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.400005e-01 | 0.268 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.400005e-01 | 0.268 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.462749e-01 | 0.263 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.524897e-01 | 0.258 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.525696e-01 | 0.258 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.565724e-01 | 0.254 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.619621e-01 | 0.250 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.619621e-01 | 0.250 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.665846e-01 | 0.247 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.665846e-01 | 0.247 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.665846e-01 | 0.247 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.756845e-01 | 0.240 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.801630e-01 | 0.236 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.801630e-01 | 0.236 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 5.976120e-01 | 0.224 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.976120e-01 | 0.224 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.000413e-01 | 0.222 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.028846e-01 | 0.220 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.060641e-01 | 0.217 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.102238e-01 | 0.215 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 6.102238e-01 | 0.215 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.143398e-01 | 0.212 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.199923e-01 | 0.208 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.224426e-01 | 0.206 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.264303e-01 | 0.203 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.303761e-01 | 0.200 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.303761e-01 | 0.200 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.342805e-01 | 0.198 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.494924e-01 | 0.187 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.531960e-01 | 0.185 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.531960e-01 | 0.185 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.568607e-01 | 0.183 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.676255e-01 | 0.175 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.711386e-01 | 0.173 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.746148e-01 | 0.171 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.780544e-01 | 0.169 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.814580e-01 | 0.167 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.848257e-01 | 0.164 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.881581e-01 | 0.162 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.881581e-01 | 0.162 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.906229e-01 | 0.161 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.914554e-01 | 0.160 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.914554e-01 | 0.160 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.947180e-01 | 0.158 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.979464e-01 | 0.156 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.011408e-01 | 0.154 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.043016e-01 | 0.152 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.105239e-01 | 0.148 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.105239e-01 | 0.148 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.135861e-01 | 0.147 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.166160e-01 | 0.145 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.166160e-01 | 0.145 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 7.175645e-01 | 0.144 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.196141e-01 | 0.143 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.239861e-01 | 0.140 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.255160e-01 | 0.139 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.255160e-01 | 0.139 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.312944e-01 | 0.136 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.312944e-01 | 0.136 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.312944e-01 | 0.136 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.505828e-01 | 0.125 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.505828e-01 | 0.125 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 7.561931e-01 | 0.121 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.571846e-01 | 0.121 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.609800e-01 | 0.119 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.609800e-01 | 0.119 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 7.660158e-01 | 0.116 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 7.732155e-01 | 0.112 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.781853e-01 | 0.109 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.804993e-01 | 0.108 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.874031e-01 | 0.104 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 7.896561e-01 | 0.103 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.018845e-01 | 0.096 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.026841e-01 | 0.095 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.282240e-01 | 0.082 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.322408e-01 | 0.080 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.456091e-01 | 0.073 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.488702e-01 | 0.071 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.551884e-01 | 0.068 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.597541e-01 | 0.066 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.790829e-01 | 0.056 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.792387e-01 | 0.056 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.811841e-01 | 0.055 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 8.867420e-01 | 0.052 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.903179e-01 | 0.050 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.926393e-01 | 0.049 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.094511e-01 | 0.041 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.117282e-01 | 0.040 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.258621e-01 | 0.033 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.292950e-01 | 0.032 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.329865e-01 | 0.030 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.364864e-01 | 0.028 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.367626e-01 | 0.028 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.410108e-01 | 0.026 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.514399e-01 | 0.022 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.565332e-01 | 0.019 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.576137e-01 | 0.019 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.582256e-01 | 0.019 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.666461e-01 | 0.015 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.798475e-01 | 0.009 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.816655e-01 | 0.008 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.827470e-01 | 0.008 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.881877e-01 | 0.005 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.985911e-01 | 0.001 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by ALK | R-HSA-201556 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.000000e+00 | 0.000 | 1 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.000000e+00 | 0.000 | 1 | 1 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
